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ALPHAVIRUSES: REVIEW OF LITERATURE 
Introduction 
Alphaviruses from the Togaviridae family are plus-stranded, enveloped RNA 
viruses. The almost 30 catalogued alphaviruses are antigenically classified into 
6 serocomplexes and have historically been divided into geographic groups that 
consist of Old World and New World alphaviruses (95, 307). Chikungunya 
virus (CHIKV), O’Nyong’nyong virus, Semliki Forest virus (SFV), Ross River 
virus (RRV), Getah virus, Sindbis (SINV) and multitudes of their derivatives 
are representatives of Old World alphaviruses, whereas Venezuelan equine 
encephalitis virus (VEEV), Eastern equine encephalitis (EEEV) and Western 
equine encephalitis (WEEV) are examples from the group of New World 
alphaviruses. Recently, phylogenetic analysis of complete genomic sequences 
of all known members of Alphavirus genus suggested its aquatic origin with 
subsequent emergence into terrestrial hosts (96). Symptomatically, infections 
with Old World viruses often result in rashes, fevers and arthritic syndromes in 
humans (390). New World alphaviruses may in turn endanger their hosts with 
encephalitis, whereas Highlands J virus (a cousin of EEEV) may cause mor-
tality in domestic birds (457). The symptoms are also behind the peculiar names 
of certain viruses. For example, O’Nyong’nyong means “weakening of the 
joints” in the Nilotic language of Uganda, while Chikungunya stands for “that 
which bends up” in the Makonde language of Tanzania. However, the geo-
graphic location of strain isolation or outbreak is more frequently used for 
naming purposes: examples include the Semliki River region of Uganda and the 
city of Sindbis in Egypt. Alphaviruses are reported to be arthropod-borne 
(arboviruses) and are maintained in natural reservoirs, which are typically 
rodents and birds, by transmission between blood-sucking insect vectors and 
susceptible vertebrate hosts, with possible transoceanic exchanges performed by 
birds. Most of the vectors are represented by mosquito species, typically from 
Aedes and Culex genera, for which alphaviral infection is usually lifelong, 
persistent and asymptomatic (390). The exceptions include Southern elephant 
seal virus from the SFV complex, for which lice were identified as vectors 
capable of transmitting alphaviruses to marine mammals (201). Vectorology of 
the deviant alphaviral relatives that infect fish species, including the eco-
nomically important rainbow trout that can be affected by Salmonid alphavirus, 
is also unclear. The transmission of fish alphaviruses is unlikely arthropod-
mediated and can even occur horizontally via direct water-borne transmission 
(254). The involvement of mosquitoes in the transmission of alphaviruses is 
responsible for the geographic prevalence of these viruses in the tropics and 
subtropics; nevertheless, significant morbidity is caused by the Sindbis-related 
Ockelbo, Pogosta or Karelian fever viruses in Fennoscandia (206). During years 
2005–2008 massive outbreaks caused by CHIKV strains in Southeast Asia, 
including India and islands in the Indian Ocean, severely affected millions of 
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people and drew great public attention. In Europe the medical status of that 
otherwise third-world problem has particularly raised after CHIKV managed to 
establish itself in a local mosquito population in Italy, albeit for short period 
(365). Additionally, VEEV and CHIKV have been added to the list of potent 
bioterrorism tools, and several nations, including the USA and the former 
USSR, reportedly developed weapons-grade VEEV, strategic stockpiles of 
which most likely still exist (35). Nevertheless, for a long time, alphavirus 
infections were not considered to be medically significant; as a consequence, 
neither vaccines for general human vaccination nor antiviral agents exist, 
making healthcare resources poorly prepared to fight against future outbreaks 
that involve Old World or New World alphaviruses. 
Two members of an Alphavirus genus, SFV and SINV, are generally 
recognized as “workhorses” of virology due to their decades of service as 
convenient models for the study of the fundamentals of virology. For historical 
reasons, SFV was a favorite pet virus in the European virology labs, whereas 
the US virological community was in favor of using SINV as the primary model 
in alphaviral research. Regardless of this division of labor, alphavirus studies 
have significantly enriched textbooks with information regarding viral repli-
cation strategies and virus-host relationships. Notable topics include virus entry 
mechanisms using clathrin-mediated endocytosis and membrane fusion 
processes, structural studies of virion organization, regulation of the progression 
of the viral replication through switching the template specificity of the viral 
replicase complex as a consequence of proteolytic maturation of its component 
proteins and also the mechanism of the production of structural proteins by 
subgenomic RNA expression under conditions of viral infection-induced host 
cell metabolism and antiviral defense suppression. Extensive studies resulting in 
a relatively deep understanding of alphaviral life principles have culminated in 
the construction of gene delivery, viral vaccine and expression vectors, earning 
a distinguished biotechnological reputation for alphaviruses (15, 240, 315, 362).  
 
 
Virion of alphavirus 
Alphaviruses are particularly famous for being excellent model systems for the 
structural studies of enveloped viruses, which have been carried out over many 
years using a variety of biophysical methods (reviewed in (167)). Cryo-electron 
microscopy and image reconstruction analyses of whole viruses yielded a 
resolution of 9 Å for both SFV (248) and SINV virions (268), while additional 
X-ray crystallographic studies of the component structural proteins and their 
complexes further advanced the field (227, 431). Evidently, alphavirus virions 
are spherical particles that are 65–70 nm in diameter with a molecular mass of 
5.2×106 Da. A single copy of an approximately 11.5-kb, plus-strand genomic 
RNA is contained within a virion, protected by several layers of macro-
molecular assemblies that ensure its structural integrity (Figure 1). The RNA 
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molecule is encapsidated by 240 copies of the capsid protein to form an 
icosahedral nucleocapsid core that is approximately 45 nm in diameter. The first 
110 N-terminal amino acids (aa) of the capsid protein could not be defined in 
the X-ray structures but are highly basic and presumed to bind to the genomic 
RNA, which does not appear to assume a regular symmetry within the 
nucleocapsid core (47, 167). The nucleocapsid is enveloped into a host-derived 
lipid bilayer, which in turn is covered by an almost continuous surface layer of 
the envelope glycoproteins E1, E2 and E3 arranged in an icosahedral lattice 
with a T=4 arrangement (47). The carboxy-terminal domain of the capsid 
protein contains a hydrophobic pocket that interacts with the carboxy-terminal 
domain (33 aa) of the E2 protein (166). The lipid membrane is enriched with 
cholesterol and sphingolipids, which are crucial for both virus entry and 
budding (382, 448). The envelope proteins are post-translationally glycosylated, 
although the glycosylation positions are not conserved among alphaviruses 
(183). In the virion E1 and E2 interact to form 240 rigid heterodimers that are 
organized into 80 trimers, which resemble spikes protruding from the 
membrane of the envelope (398, 459). 
 
 
Figure 1. The structural and genomic features of alphavirus virion (adapted from (95) 
with permission of Future Medicine Ltd). 
 
 
Alphavirus entry 
Historically, the process of receptor-mediated endocytosis was primarily studied 
using alphavirus entry models, thus, this step of virus infection has been 
described in great details (167, 219, 250, 257, 298). Nevertheless, the alter-
native pathway of alphavirus entry without involvement of endocytosis was also 
proposed (187). The E2 protein is responsible for binding to the cellular surface 
receptor(s), which are, in general, not clearly identified, although they have 
been proposed to be of a proteinaceous nature (391). Heparan sulfate may also 
assist in the initial binding steps (37, 341). The diversity of vertebrate and 
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invertebrate host types for alphaviruses suggests that either a considerably 
conserved receptor is utilized for attachment or/and multiple cellular receptors 
are employed. The existing evidence suggests that a highly abundant laminin 
receptor can be a cellular receptor for SINV entry (435). Recent study also 
identified NRAMP2 (Natural Resistance-Associated Macrophage Protein) (331) 
as an alternative receptor for SINV entry, although the generalizability of these 
findings for other alphaviruses is questionable. Eventually, receptor-bound 
virions are internalized by clathrin-dependent endocytosis (178). As the virion-
containing endosomal vesicles mature, the pH value is decreased, which leads 
to the dissociation of the E1-E2 heterodimers (433). At a neutral pH, the E2 
glycoprotein hides the underlying E1 fusion peptide, whereas at low pH, the 
destabilization of the E1-E2 complex leads to the exposure of the fusion loop at 
the distal tip of an E1 protein (395). This fusion peptide is inserted into the 
endosomal membrane, where it leads to trimerization of the E1 proteins, which 
is associated with the melting of the endosomal and viral membranes, thus 
creating a pore in the membrane that is used to deliver the nucleocapsids into 
the cytoplasm (179). The induced structural changes in the envelope surface are 
translated into a concomitant alteration of the nucleocapsid core structure, thus 
exposing the RNA molecule (118, 441). The ability of the capsid protein to bind 
ribosomes led to the development of a model in which the interaction of capsid 
proteins in incoming nucleocapsids with ribosomes facilitates nucleocapsid 
disassembly (375, 443). The putative ion-channel properties of the E1 and 6K 
proteins may also contribute to the process of RNA release into the cytoplasm 
(256, 444). 
 
 
Structural features of the alphaviral RNA 
The genomic RNA of the typical alphavirus is approximately 11,500–11,800 
nucleotides (nt) long and has 5' and 3' untranslated regions (UTRs) that are of 
varied length in different alphaviruses. There can be up to 90 nt for the 5'UTR, 
while the 3'UTR ranges from 77 nt for Pixuna virus to 609 nt for Bebaru virus 
and often contains repeats (120, 289, 348). Two protein coding regions within 
the genomic RNA are separated by an intergenic region, which is approximately 
50-nt in the case of SFV (Figure 1). Only the first open reading frame, of 
approximately 7500 nt, is employed for translation from the genomic RNA to 
produce the nonstructural (ns) polyprotein P1234, components of which 
constitute the virus-specific portion of the replicase complex (Figure 1, 2). Viral 
RNA replication starts with the synthesis of an antigenomic minus strand of 
RNA. To perform efficient minus-strand synthesis, the polymerase or its trans-
acting enhancer factor(s) must recognize a polyA fragment of at least 11 
residues and approximately 19 highly conserved residues of the 3' conserved 
sequence element (3'CSE) immediately upstream of the polyA, which appa-
rently lacks any significant secondary structure because of its high proportion of 
4 
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A/U residues (147, 148). The individual nsP4 polymerase favors binding of 
UUUUUAA in the 3'CSE and is capable of the synthesis of the full-length 
minus strand in the absence of other viral proteins in vitro (403). Nevertheless, 
as for most plus-strand RNA viruses, the 5' region of the RNA is indispensable 
for minus-strand synthesis, and the complement of the 3'CSE on the minus 
strand is a co-promoter that is important for the synthesis of the plus strand of 
the RNA (103). Interaction between these two RNA regions has been 
demonstrated in vitro (98). Additionally, cellular factors, e.g., from the trans-
lation machinery (115), or viral replicase components may assist in bringing the 
RNA ends into proximity in vivo (103). The RNA 5' region exhibits significant 
length and sequence variation among alphaviruses and is highly structured, 
comprising 4 stem-loop regions that cover almost 230 residues (288). As 
evidenced by mutagenic analyses and template competition assays, the first 
stem-loop and the AU-rich region at the very beginning of the viral genomic 
RNA are engaged in the minus-strand synthesis through the binding of a 
component of the minus-strand ternary synthetic complex to this region (128, 
280). The RNA minus strand is non-capped and non-polyadenylated; it also 
lacks polyU at the 5' end because the residues form polyA tract employed for 
synthesis initiation are not copied, but it contains unpaired guanosine at its 3' 
end (442). The minus strand or, more probably, the partly double-stranded RNA 
intermediate is a template for both genomic and subgenomic RNA syntheses. In 
the case of genome replication, the complements of the stem-loop regions on 
the 3' end of the minus strand are used as promoter elements (103). Stem-loop 1 
is critical for efficient genomic RNA synthesis, and the other stem-loop 
structures appear to act as enhancers (281). Curiously, the 51-nt sequence 
element that forms stem-loops 3 and 4 is indeed highly conserved among 
diverse alphaviruses but was shown to be required only in insect cells and not in 
vertebrate cells, suggesting its possible recognition by host-cell-type-specific 
factors (85). Subgenomic 26S RNA synthesis is initiated through the recogni-
tion of an internal conserved sequence within the minus-strand template. 
Approximately 24 nucleotides, –19/+5, constitute the minimal promoter, 
although the –98/+14 region is required for maximal efficiency of subgenomic 
RNA synthesis in SINV (447); the role of this sequence has been confirmed by 
mutagenesis and analysis of duplication of the subgenomic promoter regions 
(222, 321). The subgenomic RNA is identical to the 3' third of genome; 
accordingly, it lacks the 5' end of the genomic RNA and therefore can only be 
used as mRNA for the production of structural proteins and not as a template 
for RNA replication. Both the genomic and subgenomic RNAs are capped by 
the viral machinery and polyadenylated, likely by the terminal transferase 
activity of nsP4 (409). Approximately 10% of the newly synthesized genomic 
RNA strands become packaged into virions (415), and, although capsid 
selectivity for RNA packaging is not exceptional, the encapsidation is signi-
ficantly assisted by the presence of cis-active RNA-packaging signals in the 
genomic but not in the subgenomic RNAs (107, 233). Deletion analyses and 
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studies of defective interfering RNA species led to the identification of RNA 
elements that greatly enhance the selectivity of capsid binding and that are 
located in different parts of the ns-polyprotein coding region. Evidently, 
nucleotides 945–1076 of nsP1 region of SINV genome and nucleotides 2767–
2990 in nsP2 region of SFV genome serve as packaging signals, whereas 
several putative packaging signals were mapped for RRV (180, 445). Additio-
nally, the subgenomic RNAs of several viruses, including SFV and SINV, 
contain remarkably stable stem-loop structures within their 5' ends, allowing for 
the cap-independent translation of the structural polyprotein to overcome the 
limitations of the virus-induced shutdown of cellular macromolecular synthesis 
(104, 349, 378, 425). 
 
 
RNA replication cycle of alphavirus 
The genomic RNA molecule released from the virion is directly decoded to 
produce the ns-polyprotein, which contains essential viral components for the 
assembly of the replicase complex (355). For most alphaviruses, the translation 
of the genomic RNA predominantly yields the P123 polyprotein product, due to 
the opal termination codon (UGA) in the end of the nsP3 region (224, 225). In 
10–20% of cases, translational read-through of this termination codon results in 
an extended version of the polyprotein, P1234 (88), which also contains, in 
contrast to the prematurely terminated product, an ns-protease recognition site 
of approximately 6 residues (237) followed by the nsP4 region. Presence of an 
opal termination codon between nsP3 and nsP4 may have influence on the host-
specific infectivity (271) and contribute to virulence (414). In several 
alphaviruses from both the Old World and the New World groups, including 
SFV and several CHIKV strains, the opal terminator is absent, and the only 
translational product is P1234. The embedded ns-protease is then exclusively 
responsible for the three cleavage events within P1234 that yield several 
cleavage intermediate products and, finally, the mature nsP1, nsP2, nsP3 and 
nsP4 proteins. All of the processing intermediates and individual proteins are 
believed to play their own specific roles in the viral lifecycle (reviewed in 
(200)), which will be described and discussed in detail in the following sections. 
The viral polymerase activity provided by the nsP4 protein is accompanied by 
multiple biochemical activities from the P123 polyprotein, and in the early 
stages of infection (up to 6 h post-infection (p.i.)) is directed first towards the 
production of the antigenomic minus-strand templates which, in their turn, serve 
for the multiplication of genome-polarity RNAs (182). As evidenced by 
experiments with translation inhibitors, minus-strand synthesis requires the 
constant production of newly synthesized replicase polyproteins and ceases 
within the first 4–6 h p.i. (357, 359), whereas the synthesis of the plus strands 
continues, with an emphasis on the production of subgenomic RNAs during the 
late stages of infection due to the far more efficient initiation at the subgenomic 
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promoter compared with the genomic promoter (103). Recent measurements 
suggested that the minus-strand copy number reaches maximal values at 6 h p.i. 
and remains at this level stably until 12 h p.i., when the cell starts to die (246). 
The absolute numbers appear to be proportional to the cell size, with ~27,000 
minus strand copies in BHK-21 cells in contrast to approximately 5,000–7,000 
copies in chicken embryo fibroblasts (CEF), which have one-fifth the amount of 
RNA/cell compared with BHK-21 cells. This difference in copy numbers 
apparently indicates that the exhaustion of host factors may be a constraint on 
the total number of replication-transcription complexes (246, 437). As with all 
plus-strand RNA viruses, the RNA synthesis is asymmetric, whereas calculation 
suggests that almost 200,000 copies of each of the genomic and 26S-
subgenomic plus strands are synthesized by 8 h p.i. in vertebrate cells (415).  
 
 
 
Figure 2. Replication cycle of alphaviruses (adapted from (95) with permission of 
Future Medicine Ltd). 
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Sites of alphavirus replication 
The viral genomic RNA must participate in several competing processes, 
including translation to produce viral proteins, replication and encapsidation 
(Figure 2). Obviously, these processes must be highly regulated and therefore 
separated to avoid unwanted interference. To achieve this goal, many viruses 
induce rearrangements of the cellular membranes to create novel, virus-induced 
vesicles as the most efficient way to sequester, protect and concentrate viral 
replication-related factors and templates and to coordinate the replication steps 
(23, 62, 153, 184, 193, 231, 242, 262, 275, 282, 344, 352, 387, 440, 465, 466). 
Recent studies suggest that alphaviral replication proteins are targeted first to 
the plasma membrane, where they form spherular invaginations (109). These 
spherules appear to contain partly double-stranded replicative intermediate (RI) 
RNAs inside the cavities (200), whereas ns-proteins localise at the cytoplasmic 
side of the vesicle necks, which obviously play a role of an open channels for 
nucleotide import and product RNA export (196). It is not clear, whether the 
nature of the spherule framework is mostly membranous or whether it contains 
a proteinaceous skeleton that is covered by membrane (200). For certain viruses 
it was proposed that multiple copies of self-interacting, membrane-bound viral 
replication proteins may form capsid-like shells that resemble retrovirus and 
double-stranded RNA (dsRNA) virus virions (364). Alternative findings 
revealed that replication proteins at least from certain enteroviruses and 
flaviviruses through the recruitment of the host effector protein Arf1 GTPase 
and its guanidine exchange factor GBF1 may engage phosphatidylinositol-4-
kinase III beta to the membranes, where it mediates the synthesis of phosphati-
dylinositol 4-phosphate (PI4P) lipids, thus leading to the generation of 
organelles with unusual lipid composition and microenvironment (153). 
Analogously, recruitment of phosphatidylinositol-4 kinase III alpha (PI4KIIIα) 
by Hepatitis C virus (HCV) NS5A protein was demonstrated to contribute to the 
structural integrity of membraneous web that is formed by the vesicles of 
heterogeneous size that contain replication complexes of HCV (323). Evidently, 
both unprocessed alphaviral P123 and replicating viral RNA are needed to 
induce spherule formation (109, 345). Later, as alphavirus infection proceeds, 
the plasma-membrane-bound spherules become detached and internalized in an 
active endocytic process, requiring a functional actin-myosin network and 
phosphatidylinositol 3-kinase activity (385), although this relocalization of the 
replication complexes appears to be dispensable for RNA synthesis (109). 
Eventually, the escalation of alphaviral replication leads to the disruption of 
secretory pathway integrity and the reorganization of the internal membrane 
compartments. Therefore, at later stages of infection, the relocalized spherules 
become integrated into more complex assemblies. Finely distinguishable by 
electron microscopy, the spherules appear in large vesicular structures (0.6 to 
2 μm in diameter) designated as “type I cytopathic vacuoles”, hereafter referred 
to as CPVs (132, 303). The CPVs contain a number of double-membrane-bound 
5 
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spherules of approximately 50nm in diameter that line the vacuole membrane at 
regular intervals and are connected to the cytoplasm via necks, where the active 
replication proceeds (93, 94, 133). These cytopathic vacuoles are rich in late 
endosomal and lysosomal marker proteins (196). Nevertheless, it has not yet 
been definitively determined, whether the existing endosomes and/or lysosomes 
become internally redesigned or whether the alphaviral proteins can divert the 
new endosomes’ biogenesis pathway to establish this viral progeny-producing 
infrastructure. The intrinsic affinity of the viral replicase complex to the 
endo/lysosomal membranes appears to be unique to the togaviruses but 
apparently is evolutionarily justified (245). Ns-proteins were identified to be 
localized to the cytoplasmic face of the limiting membranes of the CPVs (112, 
196). It appears that in alphaviruses, similarly to many other RNA viruses, 
packaging of the nascent genomic RNA molecules is coupled to replication, so 
that the nucleocapsid assembly sites are adjacent to the exit pores of the CPVs 
(466). Importantly, the CPVs seem to have direct connections to the ER through 
thread-like ribonucleoprotein structures that extend from the base of the 
spherules (112). The proximity to the ER membranes is certainly not 
coincidental but provides a clear advantage in allowing in situ synthesized 
structural glycoproteins to pass into the ER and, subsequently, the Golgi (131), 
to form preassembled spikes at the outer membrane surface awaiting assembled 
nucleocapsids (119, 166, 380). 
 
 
The replicative machinery of alphaviruses 
Despite the small size of their genome, alphaviruses, as well as many other 
RNA viruses, in general demonstrate versatility and self-sufficiency in the 
functioning of self-encoded parts in the replication process (reviewed in (390)). 
Although direct, cell-free experiments testing the self-completeness of the viral-
encoded replicase entirely recreated using highly purified ns-polyprotein and its 
fragments have not yet been completed, it appears that, in terms of performing 
the actions most vital for viral RNA replication and preservation, alphaviruses 
rely mostly on themselves and not on the recruitment of host accessories. 
Obviously, being obligate parasites by definition, viruses, and alphaviruses are 
hardly an exception, divide and conquer the host resources, including the 
precisely tuned cellular nanomachinery that normally ensures the well-
established internal life of the host cell that the viruses happen to invade. 
Nevertheless, it is the viral-encoded self that secures the very existence and 
procreation of viruses, whereas the capacity to be open and communicate, 
strengthened by the evolutionarily shaped ability to balance robustness with 
genetic flexibility, determines the quality of viral life.  
As already mentioned, the alphavirus genome contains two open reading 
frames that are decoded to produce the ns- and structural polyproteins. As the 
name implies, the structural proteins derived from the structural polyprotein 
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form the enveloped virions containing encapsidated genomic RNA. In turn, the 
ns-polyprotein components are used to assemble the RNA replication 
complexes (reviewed in (200)). The viral replication machinery has a highly 
modular organization, in which the ns-polyprotein becomes divided into four 
mature component proteins during the replication process, and each of these 
mature viral proteins has a multi-domain structural organization itself (Figure 
3). For reasons of simplicity, the functionality of the replicase components is 
usually explained by describing the properties of the individual ns-proteins 
(130). However, it should be stressed that the viral replicase is evolutionarily 
designed to be formed in cis as a functionally self-contained complex system 
and that it becomes operational only as a whole. Accordingly, vital steps of 
replication, such as RNA copying, strand separating, RNA capping, protection 
of replicating RNA and others are obligatorily cooperative tasks that are shared 
by functionally interacting replicase domains, which nevertheless may 
physically belong to different mature nsP-s. Therefore, studies of the replicase 
components in isolation can hardly uncover their true functionality within the 
sophisticated structure of the replication complex. 
 
 
 
Figure 3. Modular organization of the ns-polyprotein of alphaviruses. Arrows indicate 
positions of proteolytic cleavages within P1234 polyprotein that eventually yield 
matured proteins nsP1, nsP2, nsP3 and nsP4. NsP1 features include methyltransferase 
and guanylyltransferase (MT/GT) activities in addition to membrane-binding properties 
(anchor sign). NsP2 posseses domains related to helicase and protease functions that are 
assisted by N-terminal domain (NTD); scissors indicate location of catalytic residues of 
protease. The body of nsP3 consists of macro domain and centrally located alphavirus-
unique domain (AUD) followed by hypervariable region (HVR) that apparently lacks 
regular structure and contains phosphorylation sites (PPP). N-terminal region of nsP4 
also predicted to be unstructured is presumably involved in numerous intra-replicase 
interactions and assists in RNA-dependent RNA polymerase (RdRp) activity of nsP4, 
location of catalytic residues of which is indicated by multi-pointed star.  
 
 
Notably, individual viral proteins likely retain their enzymatic properies also 
outside the context of viral replication complex. As a result, such activities may 
potentially lead to rather unpredictable consequences inside the cell. In can be 
inferred that viruses have taken measures to use some of these functionalities in 
their favor and minimize the potentially hazardous effects of others. Therefore, 
the mature viral proteins most likely have their own pathogenesis-related 
properties that are needed for the subversion of cellular homeostatic 
mechanisms and for the remodeling of the internal organization of the cell. 
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Nonstructural components of alphavirus replicase 
NsP4 protein (614 aa in SFV) is a catalytic subunit of viral replicase that 
possesses RNA-dependent RNA polymerase (RdRp) activity (335), which is a 
vital function for all RNA viruses; the single known exception is Hepatitis delta 
virus. Although the crystal structure of the alphaviral polymerase is not yet 
known, its domain organization can, to some extent, be deduced bioinfor-
matically. These analyses suggest that approximately 100 N-terminal aa resi-
dues are rather intrinsically disordered and specific for the genus Alphavirus 
only; the genetic evidence suggests that this domain participates in distinct 
interactions with other nsPs in the context of differentially functioning RNA 
synthetic complexes (337). The polymerase catalytic activity resides within the 
remainder of the nsP4, which contains signatures characteristic for RdRps, 
including a conserved GDD motif (171, 409). The alphaviral RNA polymerase 
belongs to the same group as the polymerases from Bromoviridae, Tobamo-
viridae, Tobraviridae and Hepeviridae (191, 192). RdRps are generally highly 
conserved enzymes and, because many of the solved crystal structures of the 
viral RNA polymerases follow the principally similar “fingers-palm-thumb” 
organization of sub-domains (50, 87, 278), it would not be surprising to find 
that alphaviral nsP4 follows this trend. 
Thorough studies of alphaviral RNA polymerase activity resulted in many 
details about the requirements for RNA recognition and synthesis. The initial 
experiments demonstrated that the deletion of 97 N-terminal aa residues from 
the SINV nsP4 released a soluble core segment of the polymerase that 
possessed primitive terminal nucleotidyl transferase activity, mediating the non-
templated addition of nucleotides, with a preference for adenosine, instead of 
RNA-copying activity (409). It was later shown more rigorously, using purified 
components that the N-terminal portion of nsP4 is of extreme importance. Its 
presence significantly enhanced the nucleotide transfer activity of full-length 
nsP4 compared to the Δ97nsP4 core domain alone, which suggested that the N-
terminal region may assist in RNA substrate recognition (335). The terminal 
nucleotide transfer activity of alphaviral polymerase appears to be of extreme 
importance for viral fitness. It was demonstrated that, to restore replication 
competence, SINV is capable of repairing genomes after truncations of the 
termini, regenerating the poly(A) tail and even generating new AU-rich 
sequences at the 3' ends of defective genomes or in response to introduced 
mutations within the polymerase (320). 
It was also demonstrated that the presence of unprocessed P123 is mandatory 
for the purified full-length nsP4 to synthesize minus-strand RNA de novo, 
whereas Δ97nsP4 core polymerase failed to do so (335). Interestingly, nsP4 
isolated from mammalian cells, where it was initially co-produced with 
uncleavable P123 using vaccinia virus vectors, retained the ability to synthesize 
minus strands even without P123 (403). This data favored the conclusion that 
the N-terminal domain of nsP4 acts as a molecular switch, activated by protein-
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protein interactions with P123, leading to corresponding conformational 
changes within nsP4 itself that render alphaviral polymerase capable of 
recognizing the promoter for minus-strand synthesis (335, 337). This promoter 
preference is nevertheless altered during the course of viral replication. Cross-
linking studies identified two distinct regions (aa residues 329–334 and 531–
538) within nsP4 of SINV which preferentially bound oligonucleotides 
representing the genomic and subgenomic promoters found on the minus-strand 
copy of RNA, respectively, suggesting that nsP4 itself has advanced specificity 
towards different promoters (228, 229). The change in promoter specificity 
coincides with changes in the polyprotein composition that are caused by 
sequential proteolytic processing. It was shown that the presence of unprocessed 
P123 switches nsP4 into minus-strand synthesizing mode, whereas the 
formation of the mature nsP1, nsP2 and nsP3 proteins evidently triggers further 
conformational changes within the polymerase (214–217, 370). These changes 
prevent further recognition of the promoter for minus-strand synthesis and 
instead provide for the recognition of the genomic or subgenomic promoters by 
the polymerase complex (182, 355, 359). 
To become functional, nsP4 must be released from the P1234 polyprotein 
precursor immediately after it has been synthesized. Unprocessed P1234 is 
nonfunctional as a replicase, although it contains all of the necessary 
components (214, 259, 370; Paper I). The reason for this lack of function is that 
the polymerase activity of nsP4 is dependent on its exact N-terminus, which is 
highly conserved among alphaviruses (371). Importantly, the very first aa of 
nsP4 is tyrosine, which both defines its fate as an individual protein inside the 
cell, serving as a signal according to the N-end rule in the pathway of protein 
degradation by the proteasome (464), and plays a vital role in the polymerase 
activity (371). In mutagenesis experiments, most aromatic aa residues were 
accepted as substitutions for this tyrosine, although they still led to defects in 
replication, which were compensated for by changing the putative promoter site 
for genomic RNA synthesis, mostly through the addition of AU sequences to 
the 5' end of the genomic RNA (368, 372). These genetic interactions between 
the first aromatic aa of the nsP4 and the 5' end of the viral genome may suggest 
the speculative conclusion that in the initiation of RNA synthesis the conserved 
N-terminal tyrosine may be involved in the aa templating mechanism, in which 
the functionally important tyrosine side chain can mimic a pyrimidine 
nucleobase (284, 285).  
Such proteolytic activation of polymerase activity is part of a general 
strategy for replication of several viruses and was carefully studied, for 
example, in the case of picornaviruses, which are known to employ 3CD, a 
functional intermediate product of the proteolytic maturation of the polyprotein 
(21). In the case of poliovirus, the 3C component of this precursor is functional 
as a protease, whereas the 3D polymerase (3Dpol) part is inactive until 
polyprotein processing is complete (39, 151). The initial explanation for this 
phenomenon came from structural analysis, which revealed that the N-terminal 
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glycine of 3Dpol becomes buried in a pocket at the base of the finger region 
and, through a network of hydrogen bonds, helps to correctly position the 
conserved aspartate that is involved in nucleotide selection at the catalytic site 
of the polymerase (146, 404). Therefore, the absence of the free N-terminus of 
3Dpol in its binding pocket in the case of 3CD was expected to disrupt the 
polymerase activity. Surprisingly, the structure of the poliovirus 3CD revealed 
an arrangement of the active-site residues that was very similar to that in 3Dpol, 
despite the disruption of network of interactions that was expected to position 
the key residues in the active site (249). Analysis of this data led to the 
conclusion that changes in molecular flexibility, rather than significant 
structural rearrangements, are the true determinants of polymerase activity. This 
molecular flexibility is, then, in part regulated through the insertion of the N-
terminus of 3Dpol into its binding pocket (123). The aa composition of the N-
terminus of alphaviral nsP4 suggests that it is more likely buried than exposed. 
However, whether a direct analogy can be drawn from the case of picornavirus 
and applied to alphaviral nsP4 remains to be explored. 
  
NsP1 protein (535 aa in SFV) is the main determinant of the subcellular 
localization of the replication complexes due to its intrinsic ability for 
membrane binding (304), which is mediated by the internally located 
membrane-binding peptide, aa 245–264 of SFV nsP1 (7). This region within 
nsP1 was predicted to fold into an amphipathic alpha-helix that ostensibly 
becomes inserted laterally into the membrane in a monotopic fashion so that 
hydrophobic aa residues present on one side of the helix could interact with the 
lipid acyl chains of one leaflet of the lipid bilayer and the positively charged 
residues located on the other side of the helix stabilize this construction through 
ionic interactions with the negatively charged groups of the phospholipids (208, 
386). During the course of the viral replication, the string of consecutive 
cysteine residues within nsP1, aa 418–420 of SFV nsP1, become palmitoylated, 
which determines the final anchoring of the nsP1-containing complexes (4, 
203). A distant relative of alphaviruses, Brome mosaic virus (BMV), was 
recently shown to cause membrane curvature upon the recruitment of 
membrane-shaping reticulon-homology proteins (63, 64). It is, then, an 
appealing hypothesis worthy of investigation whether multiple interactions of 
nsP1 molecules with membranes within a short distance can modulate bilayer 
curvature with possible help provided by the recruitment of specialized cellular 
proteins (26, 73, 255, 461). The special affinity for anionic phospholipids of the 
individual nsP1 protein along with its specific targeting to the plasma 
membrane results in the protrusion of filopodia by an as-yet-unexplained 
mechanism (4, 204). The induction of filopodia, leading to the formation of so-
called virological synapses (165) or tunneling nanotubes (140), is characteristic 
feature of the membrane-binding proteins of many viruses and for retroviruses 
in particular (9, 212). However, to which extent filopodia-like structures may 
contribute to the pathogenesis and serve as an additional intercellular route for 
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spreading infection between connected cells in case of alphaviruses remains to 
be further clarified. 
The nsP1 protein performs extensively collaborative work with RdRp on the 
maturation of newly synthesized plus-strand RNAs. For these actions, it 
possesses capping enzymatic activities leading to the addition of a cap-0 
structure to the 5' ends of the RNAs (5, 205, 261). Because negative strands of 
RNA are not capped, a mechanism should exist for the discrimination of the 
RNA molecules, or alternatively, distinct conformational states of the protein 
could exist, such that the capping function of the enzyme becomes activated at 
the specific point of replication. For a number of viruses, including flaviviruses 
(234), the RNA-capping domain is integrated into the RdRp protein (316), 
whereas in alphaviruses, its separation obviously provides additional options for 
control. In alphaviruses, the N-terminal region of nsP1 (aa residues 30–265) is 
conserved and is related to the methyltransferase domains of other viral and 
cellular proteins, whereas the other regions are alphavirus-specific (334). It has 
been confirmed biochemically and genetically that nsP1 has a guanine-7-
methyltransferase activity that is responsible for the transfer of a methyl group 
from an S-adenosyl-methionine donor molecule to the guanine moiety of 
guanosine-5'-triphosphate (GTP), resulting in a transient complex, whereas m7-
GMP remains covalently attached to the His-residue that is absolutely 
conserved among alphavirus-like viruses, which is His38 in the case of SFV 
nsP1 (6). This intermediate is then used to transfer the methylated GMP, in a 
guanylyltransferase reaction, onto the 5' end of the RNA with a previously 
removed γ-phosphate to finalize the capping reaction (5). The sequence of 
reactions is unique to the alpha-like superfamily of viruses, and similar findings 
were demonstrated for Bamboo mosaic virus (154), Brome mosaic virus (3), 
Tobacco mosaic virus (258) and Hepatitis E virus (244). Conventional capping 
reaction that is mediated by cellular and other viral enzymes normally proceeds 
in a way that guanylyl is first transferred to the γ-phosphate-cleaved 5' end of 
the RNA and only then is methylated at guanine position N-7, and in some 
cases also at the 2'-O position of the ribose ring to create cap-0 or cap-1, 
respectively, the latter of which is predominant in higher eukaryotes (59, 121). 
The peculiarity of the alphaviral capping mechanism thus lies in the reversed 
sequence of events, making this mechanism quite unique. Site-directed 
mutagenesis of the conserved residues implicated in capping activity results in 
loss of viral infectivity, suggesting that both of the enzymatic activities that 
participate in the capping reaction by nsP1 are vital for alphaviruses (434). This 
requirement seems obviously explicable, taking into account the important role 
that the cap structure holds for RNA stability and the efficiency of protein 
translation, as well as the fact that cellular N7-methyltransferases reside in the 
nuclear compartment and are incapable of supporting the cytoplasmic 
production of alphaviral RNA. However, it should not be overlooked that 
alphaviruses are known to cause a general transcriptional and translational 
shutdown (116, 124) and turn this shutdown into an advantage by directing the 
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cellular protein-synthesizing capacities for the exclusive production of viral 
proteins (253). Therefore, despite having their own capping apparatus, several 
alphaviruses (for example, SFV and SINV) have devised a strategy of cap-
independent translation by employing stable IRES-like stem-loop structures in 
the 5' regions of their subgenomic RNAs (104, 378) to withstand the general 
translation-initiation shutdown mediated by the impotency of eukaryotic 
initiation factor 2 (eIF2) phosphorylated by alarmed protein kinase R (PKR) to 
support cap-dependent translation (349, 425). 
Because the membrane-binding peptide is located somewhat centrally inside 
of the methyltransferase domain, it is not surprising that a feedback mechanism 
exists to allosterically regulate the capping activity of nsP1, mediated through 
its interaction with the membranes. In support of this idea, it was found that the 
depletion of phospholipids by detergents abolished the enzymatic activities of 
nsP1 in SFV, and supplementing with phosphatidylserine restored the activity 
(7); nevertheless, nsP1 of SINV did not demonstrate a similar dependence and 
remained biochemically active without any requirement for membrane 
association (410). NsP1 itself, through direct protein-protein interactions with 
nsP4, appears to be a major regulator of the promoter selectivity of the latter, 
therefore defects in nsP4 are most frequently compensated by complementary 
changes in the nsP1 coding region (84, 368). Additionally, a number of 
mutations in nsP1 leading to a temperature-sensitive (ts) phenotype were 
selected in SFV and SINV that specifically switched off the minus-strand-
synthesizing mode of RdRp. These mutations, ts11 (A348T) in SINV nP1 and 
ts14 (D119N) in SFV, lie in the methyltransferase domain, highlighting the tight 
interconnection between the functions of the polymerase and the capping 
enzyme (238, 358, 438). Interestingly, the 80 C-terminal-most aa of nsP1, being 
less conserved than the remainder of the protein are not part of methyl-
transferase domain and are predicted to be rather unstructured by the secondary 
structure prediction servers (330, 333). The aa composition of this region is 
somewhat spectacular, including a cluster of negatively charged residues that 
precedes the protease cleavage site, in contrast to the rather positive charge of 
the rest of the protein. Although the aa composition of this stretch is different in 
different alphaviruses, its presence is a common feature for most of them. 
Importantly, one of the ts-mutations of SFV, ts10 (E529D of SFV nsP1), which 
leads to a defect in viral RNA synthesis, is found in this area, suggesting that 
this non-conserved stretch is hardly random because even equivalent (acidic 
residue to another acidic) mutation is capable of disrupting this well-tuned 
macromolecular machine (239). It is tempting to speculate that by the analogy 
with NS4A of HCV (232) this negatively charged stretch in nsP1 may function 
as an electrostatic switch designed to dynamically regulate replicase activity. 
 
NsP2 protein is the largest (799 aa in SFV) of all of the alphaviral proteins and 
therefore possesses many functional elements. It is considered to be a master 
regulator of viral replication activities, expressed through a number of its 
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enzymatic activities. The domain organization of nsP2, revealed by biochemical 
and bioinformatic studies, suggests that approximately 450 N-terminal aa 
residues are distributed between three domains: an N-terminal domain of 
approximately 180 aa and two RecA-like domains, which constitute the core of 
the alphaviral helicase (99, 200). The alphavirus nsP2 sequence contains signa-
tures universally characteristic for the Superfamily 1 (SF1)-related helicases 
(81, 377), including motif I (Walker A motif) and motif II (Walker B motif). 
Motif I, sequence GVPGSGK192S in SFV nsP2, is known to be involved in NTP 
binding via the interaction of a conserved lysine residue with the β- and  
γ-phosphate groups of the NTP-Mg2+ complex, while a conserved catalytic 
aspartate of motif II, sequence YVD252EAFA in SFV nsP2, is known to interact 
with Mg2+ ions. Nucleotide triphosphatase (NTPase) (172, 324) and subtle RNA 
helicase (duplex-unwinding) activities (122) were demonstrated biochemically 
for the SFV helicase domain. SF1 helicases possess 5'-to-3' unwinding activity 
and seem to prefer stretches of single-stranded RNA adjacent 5' to the duplex 
region to initiate strand separation. For viruses bearing their own capping 
apparatus, the same active site used for NTPase activity is also used for RNA 
triphosphatase (RTPase) activity, and in accord with this shared function, the 
mutagenesis of conserved residues in the NTPase domain abolishes any RTPase 
activity as well (172). The RNA triphosphatase reaction is absolutely required 
to precede other capping reactions as it removes γ-phosphate from the 5' end of 
the RNA to which the cap structure will be transferred (421). The phenotypes of 
a number of alphaviral ts-mutants linked to the helicase domain demonstrate its 
importance for the viral replication cycle. Interesting examples include, for 
example, ts21 (C304Y in SINV nsP2), which fails to switch to subgenomic 
RNA synthesis (143).  
However, there are a number of open questions related to the actual helicase 
function; thus, it is not quite clear whether alphaviral helicase acts at the 
separation of double-stranded RNA intermediates or for the melting of 
secondary structure elements (313); nor is it clear whether it is constantly active 
or needs special triggers for activation. RecA-like domains are thought to play a 
rather simple role of the acquisition of a closed conformation upon the binding 
of NTP at the interface of domains and the relaxation of this structure upon 
NTP hydrolysis (99, 162). The physical movement of the RecA domains in 
helicases is normally translated to movement along the nucleic acid via a 
conserved motif containing an arginine residue (“arginine finger”) that directly 
interacts with the RNA, usually found in the second RecA domain (40, 207). 
For the same reason, most crystal structures of functional helicases from the 
SF1 and SF2 groups analyzed thus far contain a third helicase domain, the role 
of which is to accommodate the RNA molecule in the special cleft created 
between this domain and the tandem RecA domains and to help in the 
transformation of the NTP hydrolysis energy into RNA movement alongside 
this cleft (296, 377). This third helicase domain, which sometimes appears 
inserted between the RecA domains or adjacent to these domains in the primary 
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sequence, occupies a similar spatial position in three-dimensional space, so that 
the overall helicase structure resembles a Y-shape (100). Nevertheless, RNA-
accomodating helicase domain is usually very helicase-specific and therefore 
little or no homology is evident even between the structurally well-studied 
helicases of different flaviviruses, making the prediction of such domains 
difficult (450). Whether such a domain is present in the alphavirus ns-
polyprotein is not clear. A number of candidate domains are available for the 
putative role of the third helicase domain. The N-terminal domain of nsP2 
appears to be the most logical candidate due to its position adjacent to the RecA 
tandem domains. However, it is rather suspicious that no ts mutations were 
identified within this domain, which would then be functionally coupled to 
helicase function; whereas within the other helicase subdomains, a number of 
mutations are found in both SINV and SFV (143, 238). Additionally, in case of 
the SFV nsP2, single-stranded RNA (ssRNA) stimulated the NTPase activity 
<2-fold (122), a similar extent of stimulation was observed for NTPases from 
the Rubella virus (135) and Turnip yellow mosaic virus (168), which helicase 
domains also belong to SF1 group of helicases. At the same time, for the HCV 
NS3 helicase (SF2), which has all three domains in place, polyU is able to 
potentiate NTPase activity up to 27-fold (310), also 15- to 20-fold stimulation 
was reported in case of SARS coronavirus (399), Dengue virus (24) and Bovine 
diarrhea virus helicases (138), all of which belong to SF2 group. This 
observation provides another portion of indirect evidence suggesting that the 
helicase region of nsP2 may lack the ability to accommodate an RNA template. 
If so, then this putative third domain may be separated in the primary structure 
of ns-polyprotein and may physically reside in yet another matured ns-protein 
(such as nsP1 or nsP3). It remains to be experimentally demonstrated whether 
this assumption answers the question about the existence of possible triggers of 
helicase functionality. Certainly, another line of evidence argues against nsP2 
being a helicase whose activities are needed to displace nascent RNA chains. 
These arguments take into account the conclusion that none of the many ts 
mutations in the helicase region produces a phenotype comparable with the ones 
arising from polymerase defects, exemplified in the blocking of the elongation 
reaction (143, 238), which would be the case for a true strand-separating 
helicase. Nevertheless, the interpretation of the experimental results obtained 
with ts-mutants leads to the conclusion that the helicase domain may be 
especially important during the early stages of replication and likely shares the 
responsibility for the activation of the plus-strand-synthesizing mode of the 
alphavirus replicase complex (77). Similar conclusions were also made for 
BMV (8).  
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Figure 4. Model of the SFV protease domain built on the basis of the crystal structure 
of the VEEV protease domain, Protein Data Bank entry: 2hwk (339). Papain-like 
protease and FtsJ-like methyltransferase subdomains are marked; location of the active 
site is indicated. 
 
 
The C-terminal part of nsP2 possesses a protease activity that is responsible for 
the proteolytic maturation of the ns-polyprotein (66, 150, 259, 389). The tertiary 
structure of the corresponding domain of the VEEV has been solved at 2.45-Å 
resolution, which has provided much insight into its functionality (339). 
Structurally, the C-terminal domain of nsP2 consists of two subdomains (Figure 
4), the first of which contains the residues that constitute the catalytically active 
site, viz. Cys 478 and His 548 in case of SFV nsP2, embedded into the papain-
like fold, and the second of which is structurally related to the FtsJ-like fold that 
is characteristic of RNA methyltransferases (38). The overall fold of this viral 
papain-like protease is sufficiently unique to deserve a separate C9 family of 
alphaviral proteases within the MEROPS peptidase database (16, 322). The 
FtsJ-methyltransferase-like domain found in the protease region appears to be 
incomplete in most alphaviruses, except those operating in fish species, there-
fore its potentially redundant activity with respect to nsP1 methyltransferase 
activity could be excluded (252). Nevertheless, its scaffold definitely plays an 
important role in replication, as mutations of the conserved exposed residues 
hamper replication efficiency. Even more strikingly, the specificity determi-
nants of protease activity are shared between the subdomains, and the substrate-
accommodating cleft appears in the interdomain region (338). Additionally, the 
analysis of a number of nsP2 ts-mutants, namely SINV ts24 (G736S) and ts113 
(N700K), and alanine scanning of the conserved residues suggest that the FtsJ-
like region is directly involved in subgenomic promoter recognition (143, 252). 
Curiously, the long loop region connecting the subdomains is also conserved 
among diverse alphaviruses, suggesting that it has a more important role, 
possibly in the allosteric regulation of proteolytic activity, than being a mere 
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linker. Most importantly for this dissertation, proteolytically active alphaviral 
full-length nsP2 and the protease domain Pro (39 kDa) can be efficiently 
produced in recombinant form; thus, their properties were extensively studied 
(422, 458; Paper I and Paper III). The interpretation of the experimental results 
and their contribution to the understanding of substrate specificity and the 
regulation of alphaviral proteolytic processing are discussed in the following 
sections of this thesis. 
The processing of P1234 is found to be strictly regulated during the course 
of replication (150, 423, 463). As previously mentioned, the 3/4 site, residing 
between nsP3 and nsP4, is processed immediately after or during polyprotein 
translation. This cleavage leads to the activation of the polymerizing activity of 
nsP4, the recruitment of the viral template and the functionality of the minus-
strand-synthesizing mode of the early replicase complex P123+nsP4 (182, 215–
217, 370, Figure 2). It is not clear how many rounds (or a single one) of minus-
strand synthesis are in fact performed on a single input of a positive strand, but 
molecular genetics and replication reconstitution studies suggest that, to activate 
recognition of the genomic promoter and switch replicase efforts over to plus-
strand production, the 1/2 cleavage site located between nsP1 and nsP2 must be 
processed (182, 217). Presumably, internal replicase reconfiguration due to 
conformational changes followed by release from self-inhibition or the 
activation of additional viral transcription factors leads to the preferential 
utilization of minus-strand templates for genomic and subgenomic RNA 
synthesis. The analysis of processing in infected cells identifies P23 as an 
existing form of the polyprotein (149, 182), although in vitro experiments 
suggest that cleavage of the 2/3 site found between nsP2 and nsP3 immediately 
follows 1/2 site processing (423). In vitro experiments demonstrated that the 1/2 
site is preferentially or exclusively cleaved in cis (259, 423), while from the 
structural analysis of the protease domain it was concluded that the 2/3 site can 
become accessible exclusively in trans (339). It is generally believed that the 
2/3-site processing signifies the point of no return for the viral replication 
because mature individual proteins are incapable of supporting the initiation of 
minus-strand synthesis (216). Accumulated pool of liberated nsP2 consequently 
accounts for the swift processing of incoming P1234 polyproteins preferentially 
at the 2/3 site, thus precluding them from forming new replication foci (463). 
The existence of certain ts-mutants that are capable of reverting the activities of 
late replicase complexes to minus-strand synthesis in the presence of protein 
synthesis inhibitors is probably the best evidence that we have to conclude that 
protein-protein interactions-induced changes are indeed the main factors for the 
altered promoter-recognition preferences of the polymerase (77, 354). There 
remains a great deal of uncertainty surrounding our actual understanding of the 
sequence or extent of events; however, biochemical and structural data continue 
to accumulate, promising to eventually reveal some snapshots of reality.  
The multi-talented nsP2 protein of Old World alphaviruses has also been 
confirmed as a negative regulator of general cellular transcription and trans-
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lation to favour viral macromolecular syntheses over host ones. Transcription 
and translation inhibiting functions appear to be distinctly independent because 
certain mutations, namely of proline residues P726 in SINV nsP2 and its 
equivalent P718 in SFV nsP2, can selectively relieve the inhibition of cellular 
transcription (74, 102, 116, 126, 396). The effect of the wild-type (wt) SFV or 
SINV infection on cellular translation is so profound, however, that after just 
few hours of progressing viral replication, the cellular translation machinery 
becomes dedicated to the processing of viral mRNAs, hence viral gene 
products, especially structural proteins, become predominant in the proteome 
(253, 349, 396, 412, 425). Translation machinery subversion is evidenced from 
the recruitment of ribosomes to the sites of viral replication, potentially 
mediated by nsP2 interacting directly with the ribosomal proteins (264). 
Additionally, the accumulation of unprocessed pre-rRNAs is observed, which 
apparently indicates that the genesis of the new ribosomal units also becomes 
disturbed (116). A range of mutations affecting the nsP2 coding sequence with a 
bias to its C-terminal region were selected for the property of making viral RNA 
replication non-cytotoxic for the cell and therefore persistent in many studied 
cases (1, 41, 101, 102, 221, 301). The general conclusion that can be drawn 
from numerous studies is that mature nsP2 protein is self-sufficiently cytotoxic 
(116). It should not be left unnoticed, however, that like most biological 
entities, cytotoxicity as a property studied in the biological context (virus 
infection) is not a discrete parameter ascribed to a protein, but depending on the 
cell type, comprises a complex function of the proper localization and effective 
concentration of effector protein in the cell, which in turn is dependent on the 
intrinsic capacity of viral protein to support replication. This complexity makes 
the elucidation of the cytotoxicity determinants of nsP2 using replicating virus a 
difficult task because mutations that are expected to change a single property 
usually have more broad and unpredictable effects on replication (396; our 
unpublished data). Therefore, most mutations that hamper the release of nsP2 
from the polyprotein precursor or those that reduce its overall quantity through 
lessened viral genomic mRNA production during replication, including any 
defects in minus-strand synthesis or failure to properly switch to plus strand 
production, may result in a reduction of the toxic effect (246, 359). After the 
completion of P1234 processing or replication complex breakdown, the mature 
nsP2 protein of most Old World viruses becomes translocated into the nucleus 
due to the presence of the nuclear localization signal in its C-terminal region 
(PRR649RV in SFV) (265, 325, 326, 396, 436). This nuclear transfer is crucial 
for exhibiting the inhibitory properties of nsP2, whereas the proteolytic 
properties associated with the C-terminal part of this protein do not seem to be 
as relevant (106, 116, 117). Identified toxicity-reducing mutations, for example 
P726L or N779K in SINV, appear at the solvent-exposed loops in the structure 
and are therefore assumed to be important for as-yet-unidentified interactions 
with the cellular factors (252, 339). In any case, once in the nucleus, the excess 
of the solvent-exposed positively charged residues in this mostly basic (pI ~ 9) 
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protein and its composite organization suggest many opportunities for 
nonspecific contacts with nucleic acids and communication with potential 
partner proteins. Thus, armored with the nucleic acid structure-modifying tool 
and powered by its own energy supply, nsP2 appears to be a potentially very 
efficient transcription (interfering) factor. Not surprisingly, nucleus-residing 
nsP2 protein is also credited with antagonism of the induction of the interferon 
response during viral replication (33, 105, 108, 125, 363). Recent reports also 
suggest the involvement of nsP2 in interference with the interferon-stimulated 
Jak-Stat signaling pathway (111, 373). 
 
NsP3 protein (482 aa in SFV) for a long period of time remained rather 
enigmatic in function. Mostly due to the lack of defined enzymatic functions 
and in analogy with some proteins from other viruses, the alphaviral nsP3 
protein has been viewed simply as a possible platform that links the actively 
working units of the replicase complex (158, 345). However, this view is 
rapidly changing, and nsP3 appears to be an indispensable part of the replication 
complex, rather than an accessory protein for the improvement of viral life (78, 
127, 202, 209, 437). As evident from sequence analysis, approximately 320 N-
terminal aa residues of nsP3 are conserved among alphaviruses, and this region 
is predicted to fold into two distinct domains, whereas the C-terminal region of 
varied length is predicted to contain no regular structure and is actually 
hypervariable in sequence among different alphaviruses. The first N-terminal 
domain of nsP3 has a homology with the so-called macro domain found in 
many different organisms from archaea to mammals (145, 173); besides 
alphaviruses, macro domains appear in the proteomes of coronaviruses and 
several members of the alpha-like viruses, such as Rubella virus and HEV 
(192). Macro domain sequence and therefore overall fold is well conserved 
(297), accordingly, its structure can be reliably predicted using homologous 
modelling. Along these lines, the actual structures determined for macro 
domains, aa 2–158 of nsP3, from VEEV and CHIKV at the resolutions of 2.30 
Å and 1.65 Å respectively, yielded few, if any, surprises (247). Biochemically, 
it was demonstrated that the CHIKV and VEEV macro domains are adenosine 
di-phosphoribose 1''-phosphate phosphatases, whereas for SFV the catalytic 
activity of macro domain was at the limit of detection, suggesting that this 
enzymatic activity is not important for the viral lifecycle (79, 276). The macro 
domain of alphaviruses was shown to bind ADP-ribose, poly-ADP-ribose 
(PAR) and RNA. The structure of the macro domain complex with an RNA 
oligonucleotide revealed that RNA binding occurs slightly differently compared 
with PAR binding, although the same conserved D10 residue of nsP3 was 
involved in the specific recognition of the adenine moiety (247, 336). 
Nevertheless, the surface of the alphaviral macro domain reveals the presence of 
patches of positively charged residues that allow for the nonspecific binding of 
negatively charged polymers irrespective of the described adenine crevice. It 
was therefore proposed that the macro domain could be a non-sequence-specific 
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RNA recruitment factor or adenine-containing RNA recruitment factor to 
provide the RNA template to the neighboring ns-proteins (247). It is rather 
difficult to imagine PAR as a true substrate for alphaviral macro domain 
because poly-ADP-ribosylation is a form of posttranslational modification 
synthesized by poly-ADP-ribose polymerases (PARP) in response to certain 
stress conditions, like chemical, metabolic or radiation-induced DNA damage 
resulting in single-strand DNA breaks (405). Macro domains, including those of 
histone macroH2A1.1, are recruited to sites of PARP1 activation, directly 
sensing poly-ADP-ribosylation and acting as a platform for the other DNA-
repairing or chromatin-remodeling enzymes in the nucleus (129, 406).  
The crystal structure of the complex of alphaviral macro domain with RNA 
oligonucleotide suggests that RNA indeed can be truly biologically relevant 
substrate (247). It is interesting, however, to see possible parallels with the 
SARS coronavirus macro domain, which is adjacent to SUD (SARS unique 
domain), whose structure revealed two sub-domains with a macro domain fold; 
strikingly, this structure was hardly evident from the analysis of the primary 
sequence (164, 397). SUD, in turn, appears to form dimers, meaning that SARS 
coronavirus uses the whole set of macro domain-like units. It was proposed that 
this combination is utilized to recognize specific RNA structures including G-
quadruplexes (397). To this end, it is tempting to speculate that the revealed 
structure of the alphaviral macro domain is only half or less, if accounting for 
the possible involvement of the adjacent FtsJ-like domain of nsP2, of the full 
RNA-binding module, whereas another portion may be hidden in the central 
domain of nsP3. This domain appears to be unique for alphaviruses and has a 
suspiciously similar size to the macro domain itself, but whether it is folded 
similarly can only be revealed by future experimentation. In any case, the 
second domain of nsP3 is supposed to co-evolve with the macro domain and is 
probably implicated in the regulation of minus-strand synthesis, as concluded 
from the analysis of several ts mutants (202, 437). 
It is of special note that, to fulfill viability requirements, the minimal 
replicase of an RNA virus in principle should contain a helicase-like activity, a 
polymerase and a single-strand nucleic acid-binding protein, whereas other 
functions that aid replication may be hijacked from the cell (discussed in (318)). 
If it would be a duty of the helicase to catalyze the opening of a dsRNA 
segment and to drive rearrangements ensuring that the ssRNA product ends up 
bound to another component of the macromolecular complex, then a set of 
helping factors are expected to exist (60, 61, 296, 467). A loading factor is 
expected to facilitate the initiation of the helicase reaction, which is in vitro 
shown to be far more efficient if ssRNA overhangs are present on the dsRNA 
substrates (82, 220). A trapping factor, a single-strand binding protein, is then 
obliged to stabilize the single-stranded intermediates as they are formed to 
facilitate elongation (317). To this end, nsP3 with its accessories represents a 
very probable candidate to play the role of single-strand-binding protein, thus 
presumably assisting the RNA helicase in its functions. Such activities would 
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thus be analogous to those of RNA chaperones, which are dedicated to 
loosening RNA structures or to disrupting RNA-RNA interactions, which are 
excessively found in viral untranslated regions as well, in an ATP-binding or 
hydrolysis-independent manner (55, 319). Curiously, several proteomic studies 
identified cellular proteins hnRNP A1 (139) and hnRNP K (36) being recruited 
to the sites of alphaviral replication. These proteins shuttling between the 
nucleus and the cytoplasm are usually transient components of various 
ribonucleoprotein complexes that are involved in different aspects of RNA 
metabolism (44, 181). They are also known for RNA chaperone activities (236, 
319) that would then likely be advantageous for viral replication as well (462), 
although rather obviously, in most vital functions, alphaviruses would prefer to 
rely on themselves. 
The variable region of nsP3 is separated from a folded N-terminal region by 
a stretch of aa residues rich in serines and threonines, which inside the cells 
becomes hyperphosphorylated (78, 223, 302, 429), presumably by casein kinase 
II (430). Several ts-mutations in SINV nsP3, namely ts4 (A268V) and ts113 
(A68G), were found to lead to the production of underphosphorylated nsP3 and 
to specific defects in minus-strand synthesis (78). The complete removal of the 
hyperphosphorylated region in SFV resulted in a significantly decreased rate of 
RNA synthesis and greatly reduced the pathogenicity of SFV in mice (429). It is 
not clear at which stage of alphaviral replication cycle nsP3 becomes 
phosphorylated, although it should be noted that the introduction of such 
significant negative charge onto the surface of the replicase complex is hardly 
incidental and most obviously not without consequences (343, 453). With 
respect to the acquisition of negative charge by phosphorylation, mostly 
positively charged surfaces of the replicase could be a source of attractive 
interactions, whereas negatively charged RNA molecules could provide possi-
bilities for repulsive contacts (161). In either case, the hyperphosphorylated 
region may be envisioned as an electrostatic switch that dynamically regulates 
the properties of the replication complex, possibly through the displacement of 
another negatively charged region, such as the one noted in the C-terminal 
region of nsP1. An interesting analogy can be found with the proposed system 
of electrostatic switches in the case of HCV replication, in which a peculiar, 
negatively charged region of the HCV NS4A protein appeared to act by 
switching the hyperphosphorylation level of HCV NS5A thus affecting the 
overall replication success (232). The phosphorylation of HCV NS5A was 
proposed to cause the dissociation of this protein from the otherwise stable 
RNA replication complex to promote formation of the NS5A complexes with 
specific host proteins (80, 155). Consequently, the removal or certain mutations 
of the phosphorylated region that were introduced to reverse the assumed 
destabilization of the replication complex appeared to specifically inhibit virion 
production, suggesting that the increased stability of the replicase complex is 
inconsistent with the progression to RNA packaging; therefore, the change of 
phosphorylation status appears to be a prerequisite step for switching between 
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these closely related events (218, 402). The applicability of such a hypothesis to 
alphavirus replication events has not yet been pursued but certainly deserves 
closer inspection in the future.  
To further complicate the picture of multifarious functions of nsP3, it should 
be noted that the apparent lack of regular structure and sequence hyper-
variability of the non-conserved C-terminal region of nsP3 does not imply that 
it is unimportant. The aa composition of this region is remarkable, being rich in 
Ala, Pro, Arg and Glu residues, and, although predicted to be intrinsically 
disordered (330), the C-terminal part of nsP3 is certainly not resembling normal 
linker regions. Similar combinations of aa residues can be found in the  
C-terminal region of nsP3 in different alphaviruses, which hints at their possible 
employment as linear recognition motifs (67). A growing number of examples 
in cell biology, although relatively understudied in the world of RNA viruses, 
provide evidence that much of the molecular recognition of proteins can be 
attributed to short linear segments rather than to traditional protein-protein 
interactions involving globular domains (235, 300). These short linear motifs 
(SLiMs) are continuous regions of several aa residues that are relatively un-
constrained in sequence, with few specificity determinants (58). SLiMs can 
provide micromolar affinity with their recognition modules, ensuring the forma-
tion of transient and reversible complexes, and are therefore amenable to the 
efficient control needed in signaling pathways (65). This alternative mechanism 
for protein-protein communication should be especially beneficial for viruses, 
given the spatial constraints imposed by their compact genomes and the almost 
unlimited possibilities to interfere with well-organized cellular life with just a 
few properly selected and positioned aa residues (57, 169). Often, the presence 
of SLiMs is connected to intrinsically unstructured regions of proteins, thus 
implying the involvement of such regions in the regulatory functions of signal 
transduction (114). From this standpoint, the low-complexity, non-conserved C-
terminal region of nsP3 (and probably the C-terminal region of nsP1) can be 
viewed as an alphaviral depository of SLiMs. Although bioinformatic methods 
(67, 361) readily predict plenty of putative motifs that can potentially be 
recognized by host proteins, their true functionality and relevance of such 
interactions to alphaviral lifecycle remain to be discovered. To this end, a recent 
publication confirmed that the predicted SH3-binding motif within alphaviral 
nsP3 is functional and it can be employed to recruit amphiphysins, which are 
BAR domain-containing proteins, to the sites of alphavirus replication (277). 
Importantly, nsP3 was also reported to associate with membranes (303) and was 
found to be the main determinant of the subcellular localization of the 
alphaviral replication complexes (127, 345), whereas the region in the  
C-terminal part of nsP3 may specifically contribute to this activity (420). It can 
be inferred that the proper understanding of the ability of alphaviruses to use 
SLiMs to mimic the natural components of cellular complexes and reprogram 
the regulatory processes in the host cell may represent a gold mine for the future 
studies of alphavirus biology and antiviral research. 
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AIMS OF THE STUDIES 
A large body of evidence suggests that the RNA template preferences and 
genomic or subgenomic RNA-synthesizing capabilities of the alphaviral repli-
cation complex have very important connections with its composition, which is 
irreversibly altered by proteolysis during replicase maturation. In the past, 
numerous research projects using various polyprotein production systems, such 
as pulse-chase labeling of alphavirus infected cells, vaccinia virus-driven 
expression and in vitro translation, devised the rules for when and how ns-
protease acts. Alphaviral ns-polyprotein processing was found to be sequential 
and with a strict order of specific cleavages. The revealed characteristics of 
proteolytic processing within SFV P1234 showed that the 3/4 site is swiftly 
processed first, most probably co-translationally, whereas the 1/2 site is cleaved 
at a later time in cis, leading to almost simultaneous in trans cleavage of the 2/3 
site. Nevertheless, an understanding of the molecular basis for the processing 
rules and the triggers of the specific cleavage of a particular site at the right 
moment of the replication cycle remained rather elusive. Therefore, the aim of 
this work was to elucidate the determinants of the proteolytic processing of the 
alphaviral ns-polyprotein using defined experimental systems involving purified 
recombinant proteins along with the fine positional scanning and to shed light 
on the possible organization and functionality of the replicase complex. 
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RESULTS 
Molecular determinants of substrate  
recognition by SFV ns-protease 
From prior studies by de Groot and Strauss et al. of SINV and by Merits and 
Vasiljeva et al. of SFV ns-polyprotein processing, we inherited a wealth of data 
that confirmed that nsP2 is the protease that is solely responsible for all three of 
the cleavages in the ns-polyprotein of alphaviruses (149, 150, 182, 259, 369, 
389, 422, 423, 463). Mature nsP2 and active nsP2-containing polyproteins 
P123, P12 and P23, artificially stabilized in a non-processed form by mutating 
the penultimate Gly of the P-side of the cleavage site(s) to Val or Glu, were 
capable of cleaving all of the cleavage sites in presented polyprotein substrates, 
albeit with different efficiency (423, 463). Hereafter the designations P1-P1' are 
used to indicate the N-terminal (non-primed or P-side) and C-terminal (primed, 
P' side) regions of the substrate with respect to the cleavage position. Similar 
findings were obtained in experiments in which purified full-length SFV nsP2 
or its protease domain Pro were challenged to cleave artificial substrates 
containing a virus-specific 20–20' sequence (20 aa upstream and 20 aa down-
stream of the scissile bond) fused to a thioredoxin domain. The conclusion was 
made that the SFV 3/4 site was recognized very efficiently, the 1/2 cleavage site 
was suboptimal for protease recognition and cleavage of the 2/3 site in short 
form could not be convincingly detected (422). Several studies also noted that 
in P1234, the 3/4 and 1/2 sites are cleaved independently from all of the other 
sites, whereas the cleavage of the 2/3 site requires the preceding cleavage of the 
1/2 site to occur (150, 369, 423, 463). Assessing the sensitivity of the 
processing kinetics to the effects of dilution of the reaction components, it was 
concluded that the 1/2 site cleavage is insensitive to dilution and therefore 
occurs preferentially in cis, whereas the 2/3 cleavage is a trans reaction (150, 
423, 463). 
In early days of alphaviral ns-protease studies, Strauss et al. concluded from 
the analysis of the aa sequences surrounding the cleavage positions that a 
protease recognition site can indeed be as small as 3 aa residues, which are the 
only conserved elements in the protease cleavage motifs (390, 463). From 
sequence alignment, it can be concluded that the downstream regions of the 
cleavage sites are well conserved vertically, so that in different alphaviruses, the 
N-terminal regions of different ns-proteins generated by proteolysis are 
conserved, suggesting the conservation of the function of those proteins. In 
contrast, within a single alphaviral polyprotein, these regions have nothing in 
common (Paper I, Table 1), leading to the conclusion that the protease does not 
require the recognition of downstream regions. The upstream cleavage regions, 
in turn, have sequence similarity both vertically and horizontally. The main 
features of the non-primed region include the absolute conservation of Gly in 
the P2 position and a preference for small aa residues (Gly, Ala or Cys) in the 
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P1 and P3 positions. The P4 position in the cleavage sites of many viruses often 
contained a charged residue (Arg, His, Glu or Asp), and positions P5 and P6 
allowed considerable variation (Paper I, Table 1). These observations were in 
line with a number of studies on many types of viral proteases, indicating that 
protease recognition sites are typically relatively short (usually 5–7 aa) and 
normally reside in non-primed regions (243, 279, 392, 418, 419).  
Because the SFV 3/4 site can be efficiently cleaved in the form of an arti-
ficial substrate containing a short virus-specific sequence, it was used to map 
the minimal requirements in the substrate for efficient cleavage. To this end, a 
gradual decrease of the length of the presented virus-derived sequence, point 
mutagenesis and shuffling of half-sites of the substrates from the other (1/2 and 
2/3) sites were employed. It was found that, in the case of the 3/4 site, SFV 
protease recognized 6 aa residues upstream of the cleavage position (237). The 
P1' residue had a significant influence on the efficiency of the cleavage: bulky 
hydrophobic or negatively charged residues were clearly unfavourable, Pro was 
not tolerated at all, whereas small residues (Gly, Ser), which apparently didn’t 
interfere with the accommodation of the substrate in the recognition pocket, 
were preferred (Paper I, Figure 3). It also appeared that region P10-P7 has an 
influence on the efficiency of the cleavage (237), although elucidation of the 
extent of its effect was not pursued. Within the region composed of the 6 
recognized aa residues, we found that positions P1 and P3 allow some variation, 
and the P5 position contributes less to the recognition and can be extensively 
varied, but the Gly in the P2 position is invariably constant, and the residue in 
P4 actually determines the overall efficiency of the cleavage (Paper I, Figure 2 
and Figure 5). Experiments with the shuffled substrate half-sites generally 
confirmed the findings from the mapping and mutagenesis experiments (Paper 
I, Figure 4). Therefore, it was concluded that the 1/2 site or its analogues were 
poorly cleaved in trans due to the suboptimal His residue in the P4 position, 
which was partly compensated by the best possible residue (Gly) in the P1' 
position. In contrast, the 2/3 site was found to be deficient in signature motifs 
that would meet the minimal requirements for the recognition by the protease. 
Replacement of the Thr residue in the P4 position for optimal Arg rendered this 
site cleavable (Paper I, Figure 5); clearly, however, other elements of the 
recognition sequence were still far from the optimum to allow efficient 
cleavage. These results suggested that the P4 residue is dominant, yet not the 
ultimate, factor for cleavage proceeding; in fact, certain combinations of aa 
residues in the P6-P4 region supported by an optimum residue in the P1' 
position are the main determinants of proteolytic success. 
Experiments with viral genomes containing mutations that were supposed to 
interfere with the normal regulation of processing by making cleavage sites 
correspond better or worse to the consensus according to the established 
requirements for proteolytic activity, in general supported the in vitro findings. 
The mutations that in vitro rendered the 3/4 site less efficiently cleaved (the 
change of the Arg in the P4 position to His or Thr, as in the 1/2 and 2/3 sites, 
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correspondingly) also slowed polyprotein processing during the infection cycle 
as evidenced by pulse-chase experiments, and slightly affected RNA infectivity 
(Paper I, Figure 6). The presumed improvement of the protease recognition 
sequence in the 2/3 site (through the mutation of the Thr in the P4 position to 
Arg, as found in the efficiently processed 3/4 site) resulted in a virus that made 
larger plaques; the mutation also hastened the growth of viral titer, whereas the 
final titer and processing in particular was rather indistinguishable from those of 
the wt virus (Paper I, Figure 6). Taking into account previous knowledge that, 
after the cleavage of the 2/3 site, the replicase changes its activities in favor of 
subgenomic RNA synthesis (182, 217, 394), it can be concluded that the 
unusually rapid 2/3 cleavage switched viral replication earlier to structural 
polyproteins and virions production, thus resulting in a larger plaques. Mutation 
of the penultimate Gly together with the P1 residue (GRAGA to GRAEV) in the 
3/4 site to block its cleavage resulted in non-infectious RNA, emphasizing the 
ultimate requirement for the liberation of individual RdRp early in infection. 
Nevertheless, all of the other mutations in the cleavage sites, which were aimed 
to enhance or reduce their processivity, were well tolerated, and no reversions 
or compensatory second-site mutations were found in the region studied. This 
finding also suggests that the requirements in the protease recognition 
sequences are somewhat relaxed, which may explain their relative non-
conservation. 
It should, however, be noted that in the in vitro experiments, the 3/4 site 
cleavage was performed in trans, whereas in cell culture experiments with 
infectious virus, both in cis and in trans modes of processing can be involved. 
Two substrates containing the 3/4 site can be found in SFV infected cells – 
P1234 and P34 (Paper I, Figure 6; Paper III, Figure 1 and Figure 3). The in 
trans cleavage is the only way to process P34, and this process occurs effi-
ciently in SFV-infected cells (Paper I, Figure 6); nevertheless, its significance is 
not obvious (to note, P34 of SINV cannot be processed in late infection and 
becomes accumulated in infected cells (463). The availability of the 3/4 site for 
trans cleavage does not, however, exclude the possibility that, in the process of 
P1234 processing, this crucial cleavage is carried out intramolecularly as it was 
suggested in early studies of SINV P1234. Theoretically, the cleavage rules that 
are valid for the in cis cleavage of the 3/4 site could be different from those 
described above; however, as the results obtained in the cell-free system and in 
infected cells were highly coherent, this is unlikely to be the case. Nonetheless, 
the cis mode of cleavage may serve to potentiate the 3/4 processing and 
contribute to the high infectivity of viruses with mutated 3/4 sites (Paper I, 
Figure 6). Obtaining direct experimental proof of this mechanism or, con-
versely, ruling out this possibility proved to be extremely challenging due to the 
large size of the P1234 precursor which, coupled to the high efficiency of 3/4 
processing, did not allow us to perform dilution experiments in the manner 
previously emloyed for the 1/2 and 2/3 site processing reactions. 
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The ability of the nsP2 protease of SFV to process the 3/4 site was subse-
quently used to generate unique SFV marker viruses, in which the sequence 
encoding the marker protein became inserted between the nsP3 and nsP4 coding 
regions. The strategy of marker insertion into ns-protein region has been 
successfully used in alphavirus research, but in the described viruses the 
reporter or epitope tag has always been expressed as a fusion product with 
either nsP2, nsP3 or nsP4 (14, 29, 53, 54, 110, 127, 340). In contrast to these 
vectors, still preserving the four-ns-protein structure of the replicase region, the 
vectors constructed in our study utilized a five-ns-protein structure of the 
replicase region: the inserted EGFP marker was flanked by nsP2 recognition 
sites and is processed away from both nsP3 and nsP4 (Paper II, Figure 1). In 
these constructs, the cleavage site after the marker and before nsP4 
(marker/nsP4) consisted of 30 P-side residues, which should be more than 
sufficient to achieve optimal cleavage, as described above. Indeed, this site was 
quite efficiently processed, and only small amounts of EGFP-nsP4 fusion 
protein were detected in the infected cells (Paper II, Figure 2). The truncation of 
the P-side of this artificial site to 10 or even 6 SFV-specific residues did not 
result in any significant decrease of the infectivity of these recombinant viruses 
(unpublished results), a finding that is highly consistent with the cleavage 
requirements outlined above. The cleavage site before the marker (nsP3/marker 
site) consisted of the full P-side of the 3/4 site and had an artificial P' side 
consisting of either a P1' Gly residue followed by the natural P2'-P7' residues of 
the 3/4 site, such a site was designated as “H” for “highly efficient cleavage 
site” (Paper II, Figure 1), or of the Gly-Pro dipeptide with no aa residues from 
the native P' side of the 3/4 site, such a site was designated as “L” for “lower-
efficiency cleavage site” (unpublished data). The recombinant viruses carrying 
the “H” and “L” versions of the nsP3/marker cleavage sites turned out to be 
remarkably similar in infectivity as well as in their growth properties, and the 
processing of the “H” and “L” sites was consistently similar; only a minor 
reduction of the cleavage efficiency of the “L” site compared with the “H” site 
was observed (unpublished data). This finding was again fully in line with the 
revealed cleavage rules and indicates that the principles revealed in cell-free 
studies could be used in the design of infectious virus genomes. 
The publication of the crystal structure of the protease domain of VEEV 
nsP2 (339) allowed the homologous modeling of the structure of the SFV 
protease as well. Later, additional structure-based analysis of the substrate 
recognition pocket was performed (338) by modeling of the accommodation of 
the consensus substrate peptide at the active site of the protease, using the 
structure of the Ulp1 cysteine protease co-crystallized with its substrate (267) as 
a template. Concerning SFV protease specificity, it can be concluded that the 
substrate recognition subsites are distributed between the two sub-domains of 
the protease domain Pro region (Figure 4). The model assumed that the 
alphaviral protease accommodates a recognized peptide in the substrate pocket 
in an extended beta-strand conformation. In particular, Russo and colleagues 
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suggested that residues Ser 513, Val 515, Trp 549, Met 707 and Asp 711 
cooperatively accommodate the P4 residue of the substrate (aa positions are 
given in coordinate system of SFV nsP2). Notably, for some alphaviruses, a 
strong correlation is apparent between the charged S4 subsite residue (Lys 706 
in VEEV and Asp 711 in SFV) and the oppositely charged P4 substrate residue 
(Asp in VEEV and Arg in SFV), which are proposed to form a salt bridge, 
implying that this interaction is the key determinant for substrate specificity. 
Therefore, the molecular modeling and structural analysis by Russo et al. 
supported our experimental data concerning the requirements for the specific 
recognition of a substrate by the alphaviral protease. 
Because nsP2 is a single protease that is responsible for all three of the 
cleavages within the ns-polyprotein (259), it can be concluded that the 
accommodation of peptides representing other sites than the 3/4 site in a 
substrate recognition pocket of the protease should proceed in a similar way. 
Nevertheless, it remained completely unclear what force is driving the efficient 
processing of the 2/3 site in polyprotein context given that its immediate 
sequence adjacent to the cleavage position remains incapable of being recog-
nized on its own (422; Paper I). A preliminary search for the elements respon-
sible for the 2/3 site processing indicated that these elements are not localized in 
the nsP2 protease but instead in the N-terminal half of nsP3. Further 
experiments clarified that the 2/3 site is cleaved efficiently only if at least 165 
aa from the P' region are included in the substrate (Paper III, Figure 1). This 
fragment constitutes the full macro domain present within the nsP3 protein. The 
overall fold of this domain is well conserved from archaeal to human proteins 
that possess it (145, 173). The important feature of this domain is that its C-
terminus folds back to meet the N-terminus (79, 247), so that aa residues at the 
carboxy-terminal end of the macro domain have the possibility of contributing 
to protease recognition of the 2/3 site. In particular, the charged aa residues 
located in the C-terminal region of the macro domain (Arg 159 and Glu 163) 
were found to be necessary for the cleavage efficiency (Paper III, Figure 2 and 
Figure 3). Additionally, it was found that the N-terminal-most residues of the 
nsP2 protein are involved in the substrate recognition because even the most 
subtle deletions or extensions in this region severely affected 2/3 site cleavage 
success, whereas the enzyme represented only by the protease domain was 
completely impotent to perform this cleavage (Paper III, Figure 5). Taking into 
account the previously identified intramolecular mode of 1/2 site cleavage that 
obligatorily precedes 2/3 site processing (423, 463), it is immediately and 
appealingly obvious that the N-terminus of nsP2, which simultaneously 
represents the P' portion of the 1/2 site, has an opportunity to become placed in 
proximity with the macro domain, which comprises the P' side of the 2/3 site, 
and this increases the likelihood of their interaction. Given that a short sequence 
from the P-side of the 2/3 site apparently does not contain elements that permit 
it to be efficiently recognized by the protease substrate pocket, we concluded 
that interactions between the different domains of nsP2 and nsP3 result in an 
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assembly that directs the 2/3 cleavage sequence to the protease active center, 
thus overriding the lack of sufficiency of affinity-determining residues in the 
primary sequence preceding the cleavage position (Paper III).  
After finding that polyprotein processing is a complex function that uses 
parameters of two different types, such as the recognized sequence itself and its 
accessibility through the presentation implied by the configuration of the 
macromolecular complex, we next decided to assess the specific contribution of 
each constituent that influences cleavage efficiency for every site in the 
polyprotein. To this end, alanine scanning was employed to zero out the 
information needed for protease recognition that is contained in the side chains 
of the aa residues of the substrates, thus revealing the weight of the macro-
molecular complex-dependent component. Rather surprisingly, it was found 
that the placement of alanines in positions P6-P4 in the 1/2 and 2/3 cleavage 
sites, making the cleavage sites look like Ala-Ala-Ala-Ala-Gly-Ala and Ala-
Ala-Ala-Ala-Gly-Cys, respectively, in the context of the P123 polyprotein had 
very little if any impact on the cleavage efficiency of the 2/3 site and only 
mildly affected the cleavage of the 1/2 site in the cell-free reaction (manuscript 
in preparation), suggesting that these cleavage sites are processed in a rather 
sequence-independent manner and that the factor of complex assembly in their 
recognition is of high value. In the same conditions the efficiency of the 3/4 site 
cleavage in the context of P1234 was affected more profoundly, yet even 3/4 
site with the sequence changed to Ala-Ala-Ala-Ala-Gly-Ala, identical to the 
mutated 1/2 site, was also cleaved. Similarly, even the replacement of the P4 
Arg with Glu, thus reversing the charge in the position previously shown to 
have a significant role in 3/4 site recognition, still did not completely block the 
cleavage, suggesting that an assembly-dependent driving force can, at least to 
some extent, direct even an inappropriate 3/4 site for proteolytic cleavage. 
Importantly, all of the mutant viruses containing cleavage sites affected by 
alanine mutations were still viable and, with the exception of the 3×AAA 
mutant, in which all cleavage sites in P1234 contained Ala-Ala-Ala sequences 
in the P6-P4 region, did not incur substantial losses in initial RNA infectivity, 
replicated to the same high titers as the wt virus and did not require additional 
second-site mutations to increase their infectivity (Figure 5A). In turn, the 
3×AAA mutant revealed a severe drop in the initial infectivity but was able to 
restore its fitness to a great extent by acquiring just a single change in the 
protease recognition pocket itself, employing the mutation of Gln 706 to Arg 
(Figure 5A). The Gln 706 residue is immediately adjacent to the Met 707, 
which is the residue that was earlier proposed to be one of the subsites that are 
specifically involved in establishing contacts with the P4 residue of the 
substrate at the protease recognition pocket (338, 339). To this end, we 
hypothesized that the defect caused by 3×AAA mutation mostly originated from 
the disturbed cleavage of the 3/4 site, which processing is known to be greatly 
dependent on the cleavage sequence composition. To test this hypothesis, the P4 
Arg, the main determinant of processing of the 3/4 site (Paper I), was mutated 
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to Glu in the context of the infectious clone of SFV in order to introduce 
presumably the most unfavorable aa residue at the P4 position, the opposite 
charge of which would cause electrostatic repulsion during cleavage sequence 
accomodation at the protease active site. Rather expectedly, the genome of the 
mutant harboring the P4 Arg to Glu mutation in the 3/4 site had an initial 
infectivity only twofold lower than the genome of wt SFV, which is in line with 
our previous findings (Paper I, Figure 6). The analysis of the sequences of 
rescued viruses revealed that, in contrast to the mutations described in Paper I, 
the P4-Glu was poorly tolerated: in approximately 50% of the rescued viruses 
the pseudo-reversion to Lys occured. Most importantly, it was found that the 
pseudoreversion was not the only way to overcome the defect – in several 
clones it was compensated in the similar way as in the case of the 3×AAA 
mutant: the same residue in the protease recognition pocket was changed, but in 
this case the Gln 706 was replaced with Lys (Figure 5A). This result suggests 
that, although the structure of the replication complex assists in the recognition 
of the 3/4 site in the context of the polyprotein and helps to tolerate unwanted 
changes in it, the cleavage of the 3/4 site is certainly more sequence-dependent 
than assembly-dependent. 
Interestingly, although apparently sophisticated mechanisms exist to regulate 
the sequence of proteolytic events during the maturation of the ns-polyprotein 
of alphaviruses, the 1/2 and 2/3 cleavages themselves are still rather fitness-
improving than vitally important and indispensable, because viruses with 
blocked 1/2 and/or 2/3 sites were found to be viable and, with the help of an 
adaptive Glu 452 to Ala mutation in nsP4 (a conserved residue among 
alphaviruses), replicated with essentially the same efficiency as the wt virus 
(Figure 5B; 125, 246); in contrast, genomes with a blocked 3/4 site are 
completely non-infectious (Paper I, Figure 6). This observation is consistent 
with the view that P123 (or its multimeric complex) constitutes the core of the 
viral replicative ribonucleoprotein; accordingly, the 1/2 and 2/3 site cleavages 
can be viewed as in-core cleavages, being rather immediate sequence-inde-
pendent and replicase assembly-dependent. Therefore, their cleavage results 
from and/or reflects changes in the structure of the replication complex itself. At 
the same time, clearly, the nsP4 component of the replication complex is 
stoichiometrically underrepresented and can be viewed as an external, out-of-
core component (175, 356, 464). This view is consistent with the experi-
mentally observed properties of the reporter viruses described above: dupli-
cation of the out-of-core cleavage sites did not have detrimental effects on the 
ns-polyprotein processing and consequently on the virus viability (Paper II), 
whereas the addition of extra highly efficient cleavage sites into the in-core 
region is deleterious for the virus (Figure 5C; our unpublished results). 
Therefore, the liberation of nsP4 is more cleavage sequence-dependent and less 
assembly-dependent in case of SFV polyprotein, although the assembly-
dependent component is much more profound in case of 3/4 site of SINV 
polyprotein (463, our unpublished data). Undoubtedly, however, that because 
11
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3/4 site processing signifies the success in the initial replicase assemblage, 
resulting in nsP4 stabilization by proper installation, and starts the engine of 
replication, both parameters of processing are of greatest importance. 
 
A 
 
 
Construct RNA infectivity, 
PFU/µg 
Plaque 
size 
Second-site mutations 
SFV4 (wt) 5.0·105 normal not applicable 
SFV4-1AAA 2.4·105 small none 
SFV4-2AAA 1.6·105 small none 
SFV4-3AAA 5.0·105 normal none 
SFV4-1+2AAA 8.0·104 small multiple (found in nsP2, 
nsP3, nsP4) 
SFV4-3×AAA 3.0·102 minute Q706R in nsP2, also in nsP4 
SFV4-3×AAA-
Q706R 
8.0·104 normal not analyzed 
SFV4-34RE 2.5·105 normal Q706L in nsP2* 
 
* – or pseudoreversion of P4-Glu to Lys 
From L. Karo-Astover, V. Lulla, K. Rausalu, A. Merits and A. Lulla. Probing the plasticity of the 
alphaviral proteolytic activity by mutagenic analysis. Manuscript in preparation. 
 
Figure 5. Analysis of the properties of recombinant viruses. (A) Analysis of viruses 
with triple alanine mutations in the cleavage sites and their derivatives.  
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B 
 
Construct RNA infectivity, 
PFU/µg 
Plaque size Titer of the 1st passage, 
PFU/ml 
SFV4 (wt) 5.0·105 normal 3.0·109 
SFV4-1^2 < 1 n/a 3.2·103 
SFV4-2^3 16 small 5.0·107 
SFV4-3^4 0 n/a 0 
SFV4-1^2^3 < 1 n/a 1.1·103 
SFV4-1^2^3-EA 96 small 4.5·107 
^ – indicates blocked cleavage site; n/a – not applicable; E452A mutation was copied from 
analogous SINV mutant (125). 
From I, III and unpublished data by V. Lulla and A. Lulla. 
C 
 
Construct RNA infectivity, 
PFU/µg 
Plaque 
size 
Second-site mutations / 
reversion / pseudoreversion 
SFV4 (wt) 5.0·105 normal not applicable 
SFV4-1LGR 5.0·102 small (pseudo)reversion of 1RP4 to 
H/C/S/L 
SFV4-2LGR 5.0·105 normal none 
SFV4-1+2LGR 1.0·102 small pseudoreversion of 1RP4 to C or 
1LGRAGA → 1LGRAGV + 
V515M in nsP2 
SFV4-1LGH 4.0·105 normal 1LGH is preserved 
SFV4-1RP4 5.0·104 medium 1RP4 is preserved 
From V. Lulla, L. Karo-Astover, A. Merits and A. Lulla. Intramolecular processing timer controls 
the replication of alphaviruses. Manuscript in preparation. 
 
Figure 5. Analysis of the properties of recombinant viruses. (B) Analysis of viruses 
with blocked cleavage sites. (C) Analysis of viruses with processing-affecting 
mutations. 
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The relative insensitivity of the 1/2 site cleavage to substitutions in its sequence, 
however, does not imply that this sequence itself can be random. Our 
unpublished data suggest that reprogramming of the mode of cleavage of this 
site to be more sequence-dependent by introducing P6-P4 residues from the 3/4 
site that are favorable for protease recognition dramatically affects the viral 
RNA infectivity (Figure 5C), possibly through deregulation of the viral 
lifecycle. For such mutated virus the only means of survival turned out to be in 
the acquisition of second-site mutations in the protease recognition pocket, like 
Val 515 to Met mutation of the residue proposed to be again involved in the 
recognition of the residue in the P4 position of the substrate, and/or different 
mutations in the 1/2 cleavage site itself, most often in the P4 position, to slow 
down the artificially accelerated processing (Figure 5C). Because premature 
cleavage was found to be highly detrimental, this observation suggests that 1/2 
site cleavage should be viewed as a sort of molecular timer that controls the 
succession of specific steps in viral replication, most probably minus-strand 
synthesis. Completion of this particular step should potentially lead to 
corresponding conformational changes in the replicase core that, in turn, result 
in the proper orientation of the 1/2 cleavage sequence in the protease active site 
pocket and in cleavage occurrence. The 1/2 junction is thus a sensor in the 
transduction of a signal about the replication state, and its cleavage in its turn 
further transmits the signal that transformation of replicase core is being 
induced. This transmission is probably reflected in the new contacts of the 
nascent N-terminal end of nsP2 within the replicase core that result in 
concomitant 2/3 site cleavage that should then serve to stabilize new replicase 
construction, making its reconfiguration essentially irreversible and influencing 
the promoter-recognition properties of the viral polymerase subunit (182, 217, 
359). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
45 
 
DISCUSSION 
“For the marriage of proteolysis, a protease and  
a substrate are needed” 
Proteolytic reactions are essential to all living systems, and proteases may 
constitute up to 4% of the gene products of an organism. Different sources of 
information report about 550 defined members and a further 100 or so predicted 
human proteases (243, 311, 312, 322). The relative abundance of proteases is 
especially striking in many small RNA viruses that encode approximately 10 
gene products, of which 2–3 have protease functions (21, 71, 367, 384, 411, 
427, 460). Essentially irreversible nature of peptide bond cleavage dictates that, 
although “for the marriage of proteolysis, a protease and a substrate are 
needed”, as metaphorically suggested by Aaron Ciechanover (51), the pro-
teolytic reactions must be tightly controlled. The relationships between a 
protease and its substrates therefore require a high level of trust, whereas the 
dysregulation of protease activity, causing disruptions in a balanced life- or 
infection cycle, may thus have severe biological outcomes incompatible with 
the very existence of the biological object. The question of greatest biological 
significance is, therefore, what exactly is required for a protease to exert its 
proteolytic activity towards a substrate? 
Conventionally, a protease substrate contains a scissile bond, which resides 
between aa residues designated as P1–P1' (360). Proteases, in turn, contain a 
number of subsites, (respectively, S1, S2, etc. and S1', S2', etc.) that form a 
recognition pocket near the active site and provide varying degree of selectivity 
against particular aa residues in positions adjacent to the cleavage site. The 
intrinsic specificity of a protease is thus defined by the optimal peptide 
sequence that binds to the recognition pocket. Although certain positions in the 
vicinity of the cleaved bond may have mostly spacer value and need just to fit 
into the cleft, other substrate residues may have more prominent, affinity-
determining roles. This relative importance (conservation) of certain aa residues 
in particular locations in the substrate provides a basis for the definition of the 
recognition motifs that are preferred in substrates (43, 230, 241, 342). Digestive 
enzymes, such as trypsin, apparently have relaxed requirements for substrate 
recognition to fulfill their task. The apparent non-specificity of processive 
proteases, such as Clp, Lon, etc., whose task is to complete the degradation of 
proteins, is, in turn, compensated by their incorporation into multi-subunit 
complexes so that specific targeting is imposed by separate recognition factors, 
the activity and presence of which can be controlled by intra- and/or 
extracellular signals (70, 134, 159, 353). In contrast, non-processive and, in 
extreme cases, single-hit proteases are believed to possess high specificity 
thresholds that are implemented into their structure. An important aspect of 
specificity that also should not be underestimated is the spatiotemporal  
co-localization of a protease and its potential substrate. To this end, it should be 
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noted that approximately 20% of human proteases are membrane-bound (243). 
However, the recognition of substrates by proteases is believed to be a more 
complex process than the stochastic, diffusion-determined search for potential 
short cleavage sequences fitting into the recognition cleft with an affinity to 
match (72, 83). 
Theoretical explanations of enzyme selectivity have advanced greatly in 
transformations trying to cover different aspects of recognition specificity. The 
early “lock-and-key” concept of the regulation of enzymatic activity suggested 
the presence of rather uniquely compatible configurations (complementary 
shapes) in both the enzyme active center and the substrate for productive 
complex formation (89, 213). For practical reasons, simplified models of 
protease substrate recognition still utilize this “lock-and-key” concept, which 
implies that the side chains of aa residues constituting cleaved peptide act like 
the teeth of a key being accommodated in the keyway of the protease recog-
nition pocket, which is formed by a number of subsite aa residues. This 
assumption of the association of predetermined rigid shapes later transformed 
into the induced fit concept (194), suggesting that the binding of the substrate 
promotes the conformational reshaping of the enzyme active center. The 
substantiation of this idea led to its evolution into the now generally appreciated 
“conformational selection” paradigm of molecular recognition (31), which 
postulates that all protein conformations pre-exist and the ligand initially selects 
the most favored conformation and subsequent optimization of the backbone 
and side-chains interactions proceeds via an induced fit mechanism. The 
fundamental requirement of conformational flexibility for this theoretical model 
has found support from numerous experimental findings of the structural 
plasticity of enzymes and their substrates (141, 294).  
The description of protease specificity through the definition of a consensus 
recognition motif accounting for optimal, acceptable and disallowed residues in 
an aa sequence pattern is not a trivial task because highly specific proteases 
normally have very few natural substrates and this set of data is often 
insufficient to produce valuable guidelines for the prediction of proteolytic 
activity towards yet-unidentified substrates (20, 76, 379, 424, 428). Fortunately, 
for several proteases of the highest biological importance, the accumulated set 
of data allows for far-reaching conclusions that are believed to have broad 
applicability (188, 189). Viral proteases are excellent examples of enzymes with 
the highest specificity, and the HIV-1 protease, in particular, is an enzyme that 
has been studied in great detail. In addition to the 10 native cleavage sites 
present in the HIV gag and gag-pol polyproteins, libraries of hundreds to 
thousands of artificial sequences were screened to probe for specificity 
determinants and to define the extent of the promiscuity of HIV-1 protease 
(189, 456). The analysis of a number of structures of HIV-1 protease co-
crystallized with inhibitors or peptides representing native substrates led to the 
proposal of the “substrate envelope” hypothesis to explain HIV-1 protease 
selectivity (292, 309). It was concluded that, despite significant diversity in the 
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primary sequences, the native protease substrates tended to adopt a particular 
shape and conform to a common volume within the substrate recognition 
crevice. Accordingly, it was proposed that HIV-1 protease recognizes the shape 
of the substrate instead of particular aa residues and that those protease 
inhibitors that have atoms protruding from the consensus volume lead to the 
appearance of drug-resistance mutations in the corresponding specificity 
subsites. This appealing concept was successfully implemented in the further 
development of tightly binding inhibitors that also showed a reduced propensity 
to induce new resistance mutations and a high tolerance to the existing 
mutations (11, 46, 170, 186, 273, 274, 308). Thus, functional and structural 
studies of the basic properties of viral proteases were successfully used for the 
development of improved antiviral compounds and likely can be used in the 
case of other viruses as well (170, 328, 329, 452, 468). However, the situation 
with real substrates, which, unlike the protease inhibitors, must not only be 
bound but also cleaved, is even more complex (211). More extensive modeling 
of substrate discrimination principles using computational peptide docking of a 
large set of previously identified cleavable and non-cleavable substrates into the 
crystal structure of a protease allowed for the further evaluation of the substrate 
envelope hypothesis and in general confirmed its usefulness, although pointing 
to several limitations as well (45, 273). It was found that, indeed, the structural 
mechanism of substrate discrimination was primarily through steric interactions 
within the protease-substrate complex; however, although staying within the 
substrate envelope is necessary, it is not sufficient to determine the cleavability 
of a particular peptide. To this end, it was found that, aside from binding 
energetics alone, the ability of a peptide to adopt the appropriate catalytic 
geometry (correct angles, especially at the cleavage position between P1 and 
P1') is crucial for cleavage success (273). 
The structural presentation of the cleavage sequence to the protease active 
center is another crucial aspect of recognition because the cleavage position 
should become available for the proteolytic reaction to occur and, not 
surprisingly, proteases prefer cutting in inter-domain regions represented by 
flexible, solvent-exposed loops. Such properties of proteases were extensively 
used historically for mapping domain boundaries by performing limited 
proteolysis analysis (68, 92, 156). Unfortunately, flexibility and intrinsic 
disorder also represent major inherent obstacles for protein crystallization 
and/or assigning electron density information, thus complicating the compa-
rative analysis of the conformations of substrate residues in their native 
macromolecular context before and after interaction with a protease active site. 
However, a thorough analysis of more than 1500 crystal and solution-state 
nuclear magnetic resonance (NMR) structures of substrates, products and 
inhibitors bound to the active sites of all classes of proteases led to the 
conclusion that, universally, a protease substrate pocket accommodates ligands 
in an extended beta-strand conformation (243, 418). It is intuitively obvious that 
the structural presentation of substrates in an extended conformation should be 
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important for proteolytic enzymes with deep, narrow active site clefts which, 
along these lines, would sterically restrict access for bulkier substrates, whereas 
this requirement may be alleviated for proteases with broad and exposed 
substrate pockets. Nevertheless, several existing exceptions contradict this 
central dogma of proteolysis, and the most notable of these exceptions 
document the observed cleavages of apparently well-structured alpha-helical 
substrates identified in whole-proteome limited proteolysis (407). Currently, it 
is not quite clear whether a local unfolding of the helical substrate or a 
reshaping of the active site itself grants access to the catalytic center, although it 
is likely that both processes contribute in this dynamic conformer selection 
process.  
The very conformation of an extended beta strand suggests that the residues 
on one side of the substrate will have more intimate contacts with the pocket 
subsites. Not surprisingly, therefore, that apparent periodicity can be observed 
in the conservation of the preference of substrate residues at even or non-even 
positions (279). For example, in the case of papain-like proteases, positions P2 
and P4 are more conserved and contribute more to the binding efficiency than 
the other residues in the substrate (49, 136, 360, 416, 417). However, despite 
few salient features in the sequences of cleavable substrates, there are strong 
indications of a high degree of interdependence of various substrate residues 
(279, 293). This interdependence makes the combinatorial positional screening 
of potent residues context-dependent and thus decreases the accuracy of 
predictions of potent substrates based on its results (188, 190). Although the aa 
distribution may obviously affect the cleavage site conformation, the inter-
dependence of the substrate residues is underlined by the fact that the specificity 
subsites in the protease act cooperatively, and usually several residues with high 
conformational flexibility in the protease active site pocket constitute a subsite 
for the recognition of a particular substrate position (25, 32, 137, 283). 
Therefore, the replacement of one residue in the substrate may lead to compen-
sation for the loss of the previously preferred links by a redistribution of van der 
Waals contacts so that another residue forming a subsite pocket of the protease 
takes more responsibility for binding the mutated substrate residue (292, 468). 
Additional evidence suggests that, for a particular protease that is entitled to 
cleave similar yet distinct cleavage site sequences, substrate cleavage may 
induce changes in the protease active site conformation that may impact the 
subsequent recognition of another substrate (174, 294). Thus, with the exception 
of extreme cases, it can be expected that it would be rather difficult to predict 
the extent of cleavability of a modeled substrate from protease crystal structure 
alone (198, 293).  
The analysis of substrate specificity becomes even more complicated when 
the protease being embedded in the polyprotein is cleaving sites within it, as is 
common for viral proteases. It is a common practice for plus-strand RNA 
viruses (21, 455, 460), retroviruses (306), pararetroviruses (413) and even some 
DNA viruses, e.g., African swine fever virus (374), to employ proteases whose 
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working responsibilities include the release of stoichiometric quantities of virus-
encoded proteins and control of the maturation of virus-produced complexes 
involved in genome replication and packaging (384). Not all of the proteases 
involved in the processing of viral polyproteins are virus-encoded; however, 
host-encoded proteases, so-called proprotein convertases (13, 52, 272) are 
largely involved in the processing of virus-encoded structural polyproteins or 
the structural parts of the single polyprotein (266, 351), whereas the crucial 
cleavages within the ns-polyproteins are usually carried out by the virus’s own 
enzymes (71, 411).  
In the case of plus-strand RNA viruses, ns-polyprotein precursors produced 
directly from the genomic RNA are processed in an ordered cascade of 
cleavages; certain cleavage sites are co-translationally processed immediately, 
others are post-translationally processed in a delayed time frame by one or 
several proteases, depending on the virus. Viral ns-polyprotein processing may 
release up to sixteen mature proteins and a corresponding number of processing 
intermediates, some of which may have functions that are different from those 
of the mature proteins and are, therefore, biologically significant (388). 
Historically, the view of the importance of the polyprotein-based expression 
strategy has evolved considerably since its discovery in 1968, when it was 
presumed to represent a method by which viruses avoid the premature 
activation of their proteins, by analogy to the activation of zymogens, or a way 
in which mammalian viruses compensate for the lack of internal initiation of 
translation or overcome the restrictions resulting from the monocistronic nature 
of mammalian mRNAs (160, 393). Since then, studies carried out over four 
decades have shown that, although both of these assumptions were correct, 
many other important aspects exist. 
 
 
Alphavirus nonstructural protease –  
viral “signaling scissors” 
The results that form the basis of this thesis, corroborated by numerous studies 
by others, lead to the suggestion that the degree of mutual interdependence 
between a viral protease and its cleavage sites embedded in the viral polyprotein 
extends beyond the standard enzyme-substrate relationships, and thus, the 
complexity of its origin and purpose should be taken into account to explicate 
protease functionality, which should thus not be explained in the simple terms 
appropriate for a binary system (18, 446, 449). These complications arise from 
the mere fact of the intimate co-evolution of the protease and its substrates in a 
single body of a polyprotein (186, 376, 468), which apparently led to increased 
numbers of inter-protein contacts and enlarged areas of interacting and 
interpenetrating surfaces. To this end, the mode of proteolytic cleavage in such 
a complicated system as the viral replicase complex can hardly be strictly defi-
ned in simple cis/trans terms because the trans cleavage of one ns-polyprotein 
13 
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by another can be regarded as cis, if viewed in the context of the whole multi-
protein complex, in which every single polyprotein or its intermediate 
processing products form only a fraction of the apparently multimeric assembly 
residing on the viral RNA template (22, 48, 383, 400, 401). Importantly, this 
incorporation into a complex structure, which is usually membrane-tethered or 
even membrane-enwrapped (275, 282, 344, 465), also implies that protease 
functionality is apparently restricted in its independent decision making. 
Instead, the possibility of establishing multi-point intra-complex contacts, many 
of which can be viewed as exosite interactions, providing secondary binding 
platforms in addition to the confined area of contacts between the protease 
active site and the cleaved sequence (30, 43, 83, 113, 195, 290), provides vast 
possibilities for the allosteric regulation of enzyme conformation and thus its 
activity, as well as for the steric prevention or, on the contrary, increase in 
affinity of substrate binding. Apparently, most of the regulation triggers can be 
non-obvious and may arise from subtle changes in a distant part of the complex, 
inducing sufficient changes in the protease configuration to transduce slight 
conformational fluctuations into a more powerful signal through the structural 
transformation imposed by the proteolytic reaction. Therefore, the pattern of 
proteolytic events during viral ns-polyprotein maturation by processing can 
hardly be explained simply by the differences in the cleavage efficiencies of the 
short peptides representing the cleavage sites (211, 305). Somewhat counter-
intuitively, it becomes evident from this work that natural virus-derived 
immediate cleavage sequences, instead of being expected to provide researchers 
with hints about protease recognition preferences, are leading towards the 
opposite direction, as they appear to be fairly inefficient when taken out of 
context. In this regard, the cleavage sites within SINV ns-polyprotein represent 
apparently extreme case, since all of them appear to be invisible to their own 
protease in a short-sequence context (458). However, this situation should not 
be considered surprising, given that, in many cases, the substitution of a 
sequence-dependent mechanism of substrate recognition for an assembly-
dependent strategy could potentially lead to the extinction of recognition 
signatures in cleavage sites as becoming redundant. Additionally, the inability 
to perform sequence-dependent cleavage emerges as an additional precautionary 
measure to secure the improbability of premature accidental cleavages and 
appears to be not only evolutionarily justified but rather actively naturally 
selected.  
Proteolytic regulation was once named “signaling scissors” (269), reflecting 
the ultimate role that proteases play in cellular signal transduction. Viruses, 
although much more compact, are no less complicated, and it would be naive to 
consider the viral protease as a protein slicing machine instead of regarding it as 
an integral part of a sophisticated regulatory mechanism in signaling network. 
In line with these considerations, an appealing analogy was proposed to 
consider ns-protease in the context of viral replicase as a watchdog awaiting a 
command to bite (Paper III). This virus wellness guard is kept on a rather short 
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“chain,” being embedded into the multi-protein complex, and is fed on schedule 
when further transitions in the configuration of the replication complex become 
necessary, and thus, the proper signal to acquire the active state for the protease 
is given (e.g., by allosteric influence or by relief from inhibitory interactions or 
steric hindrance) or when the desired protein segment is forcedly targeted for 
proteolysis through exosite-driven interactions that virtually put the protein 
piece into the “mouth” of the protease to take a bite. To recapitulate, the 
replication complex is a dynamic system with many moving parts thus, it can be 
envisioned that the regulatory role of the protease is to monitor the succession 
and completion of the events of viral infection and to respond with a cleavage 
once the respective conformational changes in the complex allow the 
presentation of the scissile bond and other essential determinants. In this sense, 
the correct completion of the translation of the viral polyprotein, the capture of 
viral messenger RNA and its reassignment for genome replication, the proper 
assembly of the components of the ribonucleoprotein complex as it acquires the 
desired quaternary structure, the association with cellular membranes and 
subsequent enwrapping of the replication complexes into spherular structures, 
the completion of the replicative intermediate RNA synthesis and other similar 
events, which are most certainly accompanied by conformational transitions, 
may thus serve as valid signals for the protease to perform cleavage and to shift 
the whole system to a new level. 
 
 
Alphavirus ns-protease is designed to function in the 
context of an ever-changing genetic environment 
The readiness for reshaping of its configuration and the amenability to external 
regulation of a viral protease should be inevitably reflected in its structural 
properties. Although direct evidence for possibilities of significant confor-
mational changes of the alphaviral protease is still lacking, some analogies can 
be drawn from the studies of other protease-substrate relations which suggest 
that proteases may even “perform yoga” (291) for substrate quality control, 
whereas “inchworm” (332) or “ratcheting” (28) model mechanisms were some-
times required to explain protease preparedness to perform distinct and/or se-
quential cleavages within the polyprotein (142). Viral genomes have evolved to 
withstand the constant mutagenic pressure resulting from high error rate 
replication (69, 210, 287). They have also adapted not only to tolerate these 
random changes but to make use of them (152, 251): too little variability is as 
unfavorable as too much variability (error catastrophe, (56)). Recent obser-
vations suggest that viral proteins, especially those of RNA viruses, tend to 
possess unique biophysical features: they have many disordered regions and 
loosely packed cores, which increase their structural flexibility (451). It has 
been proposed that these properties are important for rapidly evolving viral 
sequences, providing “gradient robustness” to withstand mutational pressure 
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(408). This same flexibility may also be necessary to allow a protein to be 
involved in numerous interactions with other proteins (408, 451). Important 
properties are thus implemented in the very structures of viral proteins, and 
manifestation of this strategy in alphaviral protease seems apparent in the 
shallowness of the substrate-binding pocket that is shared between two sub-
domains constituting the protease and therefore has a high potential for con-
formational flexibility. 
Although macromolecular complex-imposed interactions apparently contri-
bute to the possibility of primary sequence-independence of substrate recogni-
tion by alphaviral protease, it is still vital to know about the intrinsic preferen-
ces of a protease specificity pocket to bind specific side chains, because potent 
protease inhibitors are most frequently mimicking the structure of a peptide 
substrate (12, 27, 230, 263, 388). It can be expected that, in principle, high-
affinity competitive protease inhibitors can to some extent control the stages of 
viral replication that are dependent on the proteolytic cleavages occurring 
outside of the replicase core; however, the only such cleavage site in the 
alphaviral ns-polyprotein does not appear to be attractive enough in this respect 
because even the minute amounts of the matured polymerase may be sufficient 
to produce inhibitor-resistant mutant genomes. Importantly, however, viral 
protease functionality is commonly not restricted in performing cleavages only 
within viral polyprotein, but proteases are extensively exploited for efficient 
subversive actions against innate immune defense mechanisms and for the 
restriction of host macromolecular synthesis to gain an advantage for the viral 
activities (42, 91, 163, 199, 226, 260, 295, 299, 314, 439, 454). In performing 
these actions, free-range protease liberated from the mature ns-polyprotein 
should be considerably more dependent on its recognition pocket abilities to 
select potential substrates, as macromolecular assembly-driven mechanisms are 
not applicable, and even the exosite-dependent component of recognition be-
comes fairly unreliable, although several exceptions arguing against this 
assumption are known, for example, Lbpro of picornaviruses (90, 91). To this 
end, even if the peptide mimetics that are being developed based on the intrinsic 
properties of a substrate pocket, and therefore on the substrate recognition 
preferences of the protease, will predictably be rather inefficient for the control 
of intra-core cleavages within the viral replicase, they may be indirectly 
efficient antivirals, acting through the relief of the host from viral protease-
dependent shutdown and providing the host defense a window in time to fight 
back (105). In this context, it should be noted that even with inhibitors that are 
created using comprehensive approaches of molecular design with best-
developed concepts like “substrate envelope” in mind to avoid protrusion from 
the consensus volume, the practice of inhibitor use suggests that, sooner rather 
than later, viral resistance eventually emerges. Resistance mutations tend to 
arise first in the protease active site pocket, resulting in changes in substrate 
recognition specificity and thus serving to exclude or diminish inhibitor binding 
(10, 144). Importantly, it appears that the perturbations do not remain local, as it 
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appears from analysis of HIV-1 protease-inhibitor complex structures that the 
active site is in fact a highly plastic and interdependent binding site, so that 
most protease residues seem to adapt to the shape of inhibitor by combining 
side-chains and backbone rearrangements throughout the enzyme, thus 
influencing both specificity and affinity, sometimes in an unexpected manner 
(86, 97, 270, 273, 286, 366). Subsequently, adjusted protease sequence specifi-
city often requires the optimization of viral cleavage sequences through 
cleavage site mutations (19, 185, 186, 328). The data presented in this thesis 
(including the unpublished data) indicate that this will more than likely be the 
case also for alphavirus protease. 
Recent research has highlighted an intrinsic capacity of even exquisitely 
specific enzymes for promiscuous functions, which form a basis for evolutio-
nary adaptability (17, 157, 177, 381). The promiscuous activity of protease 
shares the catalytic mechanism and the active site features with native activity 
but differs in substrate accommodation, thus allowing substrate ambiguity. 
Directed evolution experiments, aiming at further evolving of enzymatic 
promiscuous function, conclude that enzymes may exhibit high plasticity, 
whereas a single or few mutations may greatly increase promiscuous activity, 
leaving the catalytic efficiency largely the same (2, 176, 346). In real life, 
however, finely tuned protease specificity is evolutionarily shaped by positive 
selection for turnover rate and negative pressure to suppress otherwise 
deleterious nonspecificity (86). Our experiments aimed at probing the plasticity 
of alphaviral substrate recognition by mutagenic analysis suggested that the 
negative trade-off for evolving altered substrate specificity appears to be low for 
the alphaviral protease, which often can accept native and mutated cleavage 
sites without compromising the infectivity of the viral genome (Figure 5A, C; 
manuscript in preparation). Subsequently, the remarkable plasticity of the 
protease subsite residues at the perimeter of the active site allows the easy 
adaptation of proteolytic function against mutated cleavage sites by the 
acquisition of few mutations of protease subsite residues. Additionally, our data 
demonstrated that the plasticity not only serves to increase the tolerance to 
mutations but also provides a means for finding new, effective solutions for the 
problems created by the changes by introducing few fitness mutations, some 
changing the conformation of the substrate pocket and others possibly being 
involved in epistasis. Apparently, the constant balancing of plasticity and 
robustness is a key to the survival of ever-evolving viral species. The real-life 
situation actually appears to be even more complicated for protease inhibitors to 
persist in their actions in the reality of existence of viral quasispecies (327). The 
theory suggests that, given the error rate of viral polymerase and lack of its 
proof-reading, every single genome copy of a standard RNA virus of 
approximately 10,000 nucleotides during replication in the cell may deviate 
from consensus sequence by at least one mutation (75, 347). To this end, recent 
massively parallel sequencing studies suggested that potential protease 
resistance mutations not only can arise upon inhibitor treatment but in fact 
14 
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already exist in several copies of the replicating genome, thus leading to the 
conclusion that viruses are already prepared to escape even from inhibitors that 
are not yet invented (34, 197, 350, 426, 432). However, despite these rather 
skeptical conclusions, potential alphaviral protease inhibitors may nevertheless 
become significant, especially in combination therapy approaches. 
In conclusion, the results of the studies presented in this thesis point to the 
existence of yet another, but hardly ultimate, level of complexity in the 
regulation of alphaviral proteolytic function, which is inevitably linked to the 
genesis, dynamic transformation and fate of the viral self embodied in the 
replication complex of the virus. I believe that revealing of ever-increasing 
complexity in the lifecycle organization of even such a small object as a virus 
will never be boring, just as long as we continue to ask the right questions 
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SUMMARY 
Alphaviruses from the Togaviridae family are plus-stranded, enveloped RNA 
viruses that are transmitted by insect vectors and infect vertebrate hosts. Among 
almost thirty catalogued alphaviruses, Semliki Forest virus (SFV) and Sindbis 
virus are known as the best models for the studies of viral replication strategies 
and have a well-earned reputation as gene delivery, viral vaccine and expression 
vectors.  
The alphaviral genome is a plus-strand RNA of approximately 12kb, which 
contains two open reading frames, the first of which is directly employed for 
translation to produce virus-specific components of the replicase complex. The 
SFV replication strategy relies on the production of replicase proteins initially 
in the form of non-structural (ns) polyprotein precursor P1234, which during the 
course of replication becomes proteolytically processed by the virus-encoded 
nsP2 protease in a temporally regulated manner to eventually release four ns-
proteins. Mature ns-proteins of alphaviruses exhibit multiple activies that are 
vital for the replication process, whereas polyprotein processing intermediates 
evidently possess functionalities different from mature proteins and are, 
therefore, biologically significant as well. Temporally controlled ns-polyprotein 
processing thus defines regulation of the viral RNA replication presumably by 
causing rearrangements of the viral replication complex, so that its RNA 
template preference is changed in favour of minus-strands over plus-strands 
during the course of viral infection. Numerous studies have devised rules for 
when and how ns-protease acts at processing of P1234 polyprotein. To this end, 
it was revealed that during maturation of the replicase complex the 3/4 site 
cleavage is the first to take place, which later as infection progresses is followed 
by in cis cleavage of the 1/2 site, in turn triggering concomitant in trans 
cleavage of the 2/3 site. The molecular grounds behind the processing rules 
have been largely unexplored and the true understanding of the essential 
triggers leading to sequential order of processing remained rather elusive at the 
starting point of the presented studies.  
Initial experiments that were aimed at dissecting the requirements for the 
efficient in trans processing of the SFV 3/4 site utilised assays that employed 
recombinant protease and substrate variants. These analyses revealed that the 
main determinants of the cleavage efficiency are located in the region preceding 
the scissile bond and that the protease recognizes at least the residues P5 to P1′. 
In this context, the amino acid (aa) residues in positions P5 and P1′ tolerated 
much of variation without compromising cleavage efficiency, small aa residues 
were preferred in positions P1 and P3, P2 Gly was concluded to be invariant 
and the properties of the residue in P4 position modulated the efficiency of 
processing to the largest extent. The results obtained in the cell-free test system 
correlated with those obtained using cells infected with the targetedly modified 
viruses, although the effects of the introduced mutations on the viral replication 
in the infected cells were significantly less profound. The knowledge about the 
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SFV protease preference in processing the 3/4 site was subsequently used to 
generate unique SFV marker viruses, in which the sequence encoding the 
marker protein flanked with protease cleavage sites became inserted between 
the nsP3 and nsP4 coding regions. Furthermore, it was found that, besides the 
optimal short sequence immediately adjacent to the cleavage position, 
additional factors should exist to assist the spatiotemporal regulation of 
proteolysis.  
Analysis of the requirements for the efficient processing of the 2/3 site, 
which evidently lacks primary sequence elements in the vicinity of the scissile 
bond sufficient for efficient cleavage, revealed that the specific factors residing 
outside of the protease domain determine the substrate recognition and thus 
decide the outcome of proteolytic reaction. These findings supported a model in 
which structural elements within the C-terminal region of the macro domain of 
nsP3 are used for precise positioning of a 2/3 substrate cleavage sequence at the 
catalytic center of the protease and that this process is coordinated by the exact 
N-terminal end of nsP2, thus representing a unique regulatory mechanism used 
by alphaviruses. The conclusion that correct macromolecular assembly as well 
as transformations within the multi-protein complex, presumably strengthened 
by exosite interactions rather than the functionality of the individual nsP2 
protease, emerges as an indispensable driving force for specific substrate targe-
ting, paved the way to subsequent experiments, in which positional scanning, 
aimed to zero out cleavage site sequence-dependent effects on efficiency of 
substrate recognition, was employed to assess the extent of assembly-dependent 
recognition. The obtained data suggested that the macromolecular assembly-
dependent processing undoubtedly contributes to the capability of the virus to 
survive and adapt even to the situation, in which all affinity-determining 
residues in all three cleavage sites of P1234 were knocked-out by alanine 
mutagenesis, essentially preserving the order and timing of the processing or 
restoring these parameters through adaptive non-cleavage site mutations. 
Nevertheless, the primary sequences of 1/2 and 3/4 sites appear to be evolutio-
narily selected to ensure their slow/delayed or swift cleavages, respectively. 
Therefore, interventions into these cleavage sites’ sequences in order to delay 
3/4 site cleavage or, especially, to artificially speed up the cleavage of 1/2 site 
were found to cause seriously detrimental effects on the viral infection. 
Consequently, such defects were not tolerated in the viral genome and required 
corrections such as (pseudo)reversions, mutations in the cleavage sites or in the 
subsites of the substrate recognition cleft in the protease domain.  
Combined, the results of the studies described in this thesis pointed to the 
conclusion that the processing of the SFV ns-polyprotein is a complex process 
regulated by the multi-layered control system that prevents from premature 
proteolytic events and guarantees timely cleavages according to the require-
ments of the particular stage of viral replication. The alphaviral protease 
therefore emerges as an integral part of the sophisticated signaling mechanism, 
in which the regulatory task of the protease consists of monitoring the 
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succession and completion of the events of viral infection. Once the respective 
replication status-induced conformational changes within replicase allow the 
presentation of the scissile bond and/or other essential determinants of substrate 
recognition like exosites, the local protease signaling is initiated, which appa-
rently leads to reconfiguration of the viral replication complex. Importantly, the 
studies unveiled the decisive role played by the macromolecular assembly-
dependent component of substrate recognition in addition to the sequence-
dependent component, the combination of which may be expected to constitute 
the basis of regulation in multi-site proteolytic systems in general. Further 
evaluation of this concept may provide valuable insights into the proteolytic 
regulation of replication in other viruses, a gene expression strategy of which 
relies on the production of viral polyprotein precursors. Indeed, this work has 
confirmed that the intra-replicase contacts are at least of the same importance as 
the individual properties and activities of matured viral proteins. Described 
findings and their interpretations are, thus, expected to provide with essential 
grounds and directions for further studies on the restriction of alphaviral 
replication through affecting the center of viral proteolytic activity or via 
intervention with its regulation by targeting intramolecular interactions that 
determine the stability and functionality of the viral macromolecular 
assemblies. 
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SUMMARY IN ESTONIAN 
Alfaviiruse mittestruktuurne proteaas ja  
tema liitvalgust substraat:  
täiuslikult korraldatud kooselu reeglid 
 
Alfaviirused (sugukond Togaviridae) on positiivse RNA genoomi ja lipiidse 
ümbrisega sfääriliste virionidega viirused, mis peale oma selgroogsete pere-
meeste nakatavad ka putukatest ülekandevektoreid. Ligikaudu kolmekümnest 
teadaolevast alfaviirusest on enim uuritud Semliki Forest viirust (SFV) ja 
Sindbis viirust, mis on kujunenud olulisteks mudelsüsteemideks ning tööriista-
deks geeniülekandes ja -vaktsineerimisel. 
Ligikaudu 12 kb pikkune genoomne RNA sisaldab kahte avatud lugemis-
raami, millest esimest transleeritakse otse genoomselt RNA-lt ja mis kodeerib 
replikaasi viirus-spetsiifilisi komponente. SFV puhul ekspresseritakse need 
komponendid ühe liitvalgu, P1234 polüproteiini, kujul ja see lõigatakse polü-
proteiinis paikneva nsP2 proteaasi poolt ajaliselt täpselt reguleeritud prot-
sessingu käigus valmis mittestruktuurseteks (ns) valkudeks (nsP1-nsP4). Kõik 
ns-valgud on multifunktsionaalsed ning olulised viiruse infektsiooniks. Peale 
selle on varasemad uurimised näidanud, et ka P1234 polüproteiin ja selle 
lõikamise vaheproduktid omavad bioloogilisi aktiivsusi, mis valmis ns-valkudel 
puuduvad, ning on samuti infektsiooniks olulised. Seetõttu on erinevaid katse-
süsteeme kasutades ns-valkude ekspressiooni ja valmimist põhjalikult analüüsi-
tud. Need tööd on näidanud, et ns-polüproteiinide ajaliselt kontrollitud prot-
sessing koordineerib viiruse infektsioonitsükli kulgemist, aktiveerides alguses 
viiruse RNA replikaasi ja muutes seejärel tema spetsiifilisust nii, et replikaas 
hakkab sünteesima viiruse positiivseid RNA-sid. Nende tööde tulemusena on 
kindlaks tehtud ka P1234 lõikamise reeglid. Nii on näidatud, et replikaasi 
moodustumisele viiv protsessing algab viimase (3/4) saidi lõikamisest, millele 
järgneb 1/2 saidi in cis lõikamine ning et see sündmus käivitab viimasena 
toimuva 2/3 saidi in trans protsessimise. Samas olid sellise lõikamiste järjekorra 
taga seisvad molekulaarsed mehhanismid käesoleva töö alustamise ajal suurel 
määral tundmatud. 
Käesolevas väitekirjas kirjeldatud tööde käigus iseloomustati kõigepealt 
SFV 3/4 saidi protsessimise mehhanismi. Rekombinantseid substraate ja 
ensüüme kasutades näidati, et selle saidi lõikamise peamised determinandid 
paiknevad lõigatavast peptiidsidemest ülalpool. 3/4 saidi puhul tunneb proteaas 
ära vähemalt kuute aminohappe (ah) jääki, mis paiknevad positsioonides P5-P1'. 
Nende ah-jääkide roll ei ole aga ühesugune: kui P1' positsioonis (aga ka P5 
positsioonis) paiknev ah-jääk mõjutas lõikamise efektiivsust suhteliselt vähe, 
siis P1 ja P3 positsioonides olid tugevasti eelistatud väikesed ah-jäägid. P2 
positsioonis oli absoluutselt vajalik glütsiinijääk ja protsessingu efektiivsuse 
peamiseks mõjutajaks osutus P4 ah-jääk. Saadud tulemuste kontrollimisel 
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nakatatud rakkudes selgus, et, ehkki viiruse genoomi viidud mutatsioonide 
efektid P1234 protsessingule olid sarnased rakuvabas süsteemis nähtutele, 
mõjutasid need mutatsioonid viiruse infektsioonilisust üllatavalt vähe. Samuti 
osutus võimalikuks lisada SFV nsP3 ja nsP4 regioonide vahele täiendav valk 
koos ülal toodud reeglite alusel konstrueeritud kunstlike lõikamissaitidega. 
Need andmed viitavad sellele, et P1234 protsessingus on oluline roll ka mehha-
nismidel, mis ei ole otseselt seotud lühikese ah-järjestuse äratundmisega 
proteaasi poolt. 
Selliseid mehhanisme kirjeldati esmalt analüüsides detailselt 2/3 saidi, milles 
puuduvad selle äratundmist võimaldava ah-järjestused, protsessimist. See 
uurimus näitas, et nimetatud saidi lõikamine ei põhine lühikese ah-järjestuse 
äratundmisel nsP2 proteaasi domääni poolt vaid et selles osaleb ka nsP2 N-
terminaalne regioon, ning, mis eriti oluline, lõikamiskohast ligi 160 ah jäägi 
kaugusel nsP3 macro-domääni C-terminaalses alas paiknev regioon – eksosait. 
Ilmnes, et see regioon osaleb 2/3 saiti sisaldava substraadi täpses paigutamises 
nsP2 aktiivsaiti ja et seda protsessi koordineerib nsP2 N-terminus: ainult juhul, 
kui kõik nimetatud komponendid paiknesid üksteise suhtes õiges konfigurat-
sioonis, toimus 2/3 saidi efektiivne lõikamine; juhul, kui mõni element puudus, 
oli defektne või oli rikutud nende vastastikune paiknemine, lõikamist ei toimu-
nud. Seega osutus 2/3 saidi lõikamise mehhanism uudseks ja selle saidi prot-
sessing sõltuvaks viiruse valkude poolt moodustatud makromolekulaarsest 
struktuurist. Järeldust, et just korrektsete makromolekulaarsete struktuuride 
moodustamine (aga ka nendes struktuurides toimuvad muutused) ja interakt-
sioonid eksosaidiga omavad proteaasi toimimise reguleerimisel peamist rolli 
kinnitasid ka järgnevad uurimused. Nii näitas läbiviidud positsiooniline 
skanneerimine, et isegi juhul kui kogu lõikamissaitide järjestuses paiknev infor-
matsioon ära nullida (muuta kõik saidid ühesugusteks järjestusega Ala-Ala-Ala-
Ala-Gly positsioonides P6-P2) suudab viirus adapteeruda ja korrektse 
lõikamisjärjekorra säilitada või taastada kas pseudoreversioonide või kompen-
satoorsete mutatsioonide tekkimise abil. Peale selle selgus, et 3/4 ja 1/2 saitide 
järjestused on evolutsiooni käigus välja kujunud selliselt, et tagavad vastavalt 
nende kiire (3/4) ning, vastupidi, piisavalt aeglase (1/2) lõikamise. Viimane on 
ilmselt vajalik võimaldamaks viirusele oluliste bioloogiliste protsesside (tõe-
näoliselt negatiivse RNA sünteesi) läbiviimist, mistõttu on selle kiirendamine, 
sarnaselt 3/4 saidi lõikamise blokeerimisele, viirusele fataalne. Siiski olid ka 
sellised mutandid võimelised infektsioonilisust taastama, tehes seda taas 
mutatsioonide tekkimise abil kas proteaasi lõikesaiti ja/või vastavas subsaidis 
proteaasi substraati äratundvas ja seondavas regioonis. 
Kokkuvõttes näitasid käesoleva väitekirja aluseks olevad uurimised, et SFV 
P1234 protsessimine on kompleksne protsess, mida reguleerib mitmetasandiline 
kontrollsüsteem, mis tagab selle, et ennetähtaegsed (ja muud viiruse eksisteeri-
misega mittekokkusobivad) lõikamised on välistatud, samal ajal kui on tagatud 
viirusele oluliste lõikamiste efektiivne ja õigeaegne toimumine replikatsiooni-
tsükli kindlates faasides. Saadud andmed lubavad väita, et alfaviiruse proteaas 
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kujutab endast osa elegantsest signaali ülekandmise mehhanismist ja et tema 
peamine roll seisneb viiruse infektsioonitsükli käigu “jälgimises”. Selle prot-
sessi käigus tunneb proteaas ära viirusele oluliste sündmuste toimumisega kaas-
nevad muudatused replikaasi struktuuris, millega kaasnevad kindlate lõike-
saitide ja/või muude oluliste elementide (nagu eksosaidid) kättesaadavaks 
muutumine. Sellistele sündmustele järgnev lõikamine muudab toimunud ümber-
korraldused replikaasis praktiliselt pöördumatuks. Saadud andmed näitasid 
selgelt, et lisaks lõikesaitide järjestustele on selles protsessis oluline roll repli-
kaasi moodustavatel makromolekulaarsetel struktuuridel; nende faktorite oma-
vaheline koostoime kujutab endast „jõudu“, mis tagab paljudest lõikamistest 
koosneva protsessingukaskaadi toimumise ja regulatsiooni. Kuna ka teiste 
polüproteiine ekspresseerivate viiruste proteaasid võivad nende viiruste infekt-
siooniprotsessides omada sarnast rolli, omavad saadud tulemused tähtsust nii 
erinevate viiruse infektsiooniprotsessiga kaasnevate sündmuste lahtimõtesta-
misel, kui ka viiruse proteaaside vastu suunatud inhibiitorite kavandamisel. 
Peale selle näitavad saadud tulemused, et lisaks traditsioonilistele proteaasi 
inhibiitoritele eksisteerib võimalus kavandada ka uut tüüpi inhibiitoried, mille 
toime seisneks proteaasi töö regulatsiooni rikkumises ja selle kaudu aktiivse 
replikaasi moodustamise takistamises. 
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